Quarterly Report • Nov 16, 2017
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group I Quarterly Report – 3Q2017 I p.1
Summary 4
The core of our strategy 5
Overview of our results and balance sheet 6
Analysis of the quarter 7
Analysis of the year-to-date period 10
Risk statement 10
Our views and guidance 11
Consolidated income statement 13
Consolidated statement of comprehensive income 14
Consolidated balance sheet 15
Consolidated statement of changes in equity 16
Consolidated cash flow statement 17
Notes on statement of compliance and changes in accounting policies 17
Notes on segment reporting 18
Other notes 19
Statutory auditors' report 29
Credit risk 32
Solvency 38
Income statement per business unit 42
Details of ratios and terms 50
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
[email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 16 November 2017
Check this document's authenticity at www.kbc.com/en/authenticity .
Report for 3Q2017 and 9M2017
Against the background of sustained economic expansion, only moderately rising inflation, a stronger euro and stable low interest rates, KBC turned in a strong performance in the third quarter of 2017, posting a net profit of 691 million euros. In the quarter under review, our core businesses once again performed well, while costs remained under control and the level of loan loss impairment remained very low. Moreover, the recently acquired Bulgarian companies also contributed positively to net profit. Adding the third quarter result to the similarly very good results for the first two quarters of the year brings the net result for the first nine months of 2017 to 2 176 million euros, significantly up on the 1 742 million euros recorded in the corresponding period of 2016. Our solvency and liquidity positions remained strong too. In line with our dividend policy, we will pay an interim dividend of 1 euro per share on 17 November 2017.
'We have delivered yet another strong performance in the third quarter. A number of factors were instrumental in achieving this, including growth of net interest income, solid net fee and commission income and a high level of insurance income thanks in part to some releases of provisions. Moreover, our costs remained under control, and loan loss impairment charges continued to be very low. On top of that, our recently acquired Bulgarian entities UBB and Interlease contributed 14 million euros to this quarter's result. Moreover, the quarterly result was also influenced by an ongoing industry wide review of the tracker rate mortgage products originated in Ireland before 2009, for which a negative 54 million euros in this quarter has been booked.
All this resulted in 691 million euros of net profit being posted in the quarter under review. Combined with the 630 million euros recorded in the first quarter, and the exceptionally strong 855 million euros in the second quarter, this brings our net result for the first nine months of 2017 to 2 176 million euros, up 25% on the figure for the corresponding period of 2016.
We continued to work relentlessly on executing our strategy, which has proven very successful to date. We are on track as regards our digital agenda, and are working on further developing our bank-insurance business and on supporting the local economies and clients in the countries in which we operate. We are ahead of our agenda on the operational integration of the recently acquired UBB and Interlease entities in Bulgaria, which will make us a leading player in that core country too.
We are truly grateful for the trust that our clients place in our company and our employees, and remain fully committed and focused in our efforts to become the reference in client-centric bank-insurance in all our core countries.'
| Overview KBC Group (consolidated, IFRS) | 3Q2017 | 2Q2017 | 3Q2016 | 9M2017 | 9M2016 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 691 | 855 | 629 | 2 176 | 1 742 |
| Basic earnings per share (in EUR) | 1.62 | 2.01 | 1.47 | 5.11 | 4.07 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 455 | 483 | 414 | 1 240 | 993 |
| Czech Republic | 170 | 183 | 145 | 534 | 465 |
| International Markets | 78 | 177 | 106 | 370 | 289 |
| Group Centre | -12 | 12 | -36 | 32 | -5 |
| Parent shareholders' equity per share (in EUR, end of period) | 40.6 | 39.8 | 36.2 | 40.6 | 36.2 |
Our core strategy remains focused on providing bank-insurance products and services to retail, SME and mid-cap clients in our core countries of Belgium, Bulgaria, the Czech Republic, Hungary, Ireland and Slovakia.
Our strategy consists of four interacting cornerstones:
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section.
| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
3Q2017 | 2Q2017 | 1Q2017 | 4Q2016 | 3Q2016 | 9M 2017 |
9M 2016 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 039 | 1 028 | 1 025 | 1 057 | 1 064 | 3 091 | 3 201 |
| Non-life insurance (before reinsurance) | 188 | 179 | 187 | 178 | 164 | 554 | 450 |
| Earned premiums Technical charges |
378 -190 |
369 -190 |
360 -173 |
363 -185 |
357 -193 |
1 107 -553 |
1 047 -597 |
| Life insurance (before reinsurance) | -3 | -24 | -28 | -44 | -34 | -55 | -107 |
| Earned premiums Technical charges |
282 -284 |
267 -291 |
312 -341 |
413 -457 |
336 -370 |
861 -916 |
1 163 -1 271 |
| Ceded reinsurance result | 16 | -10 | -4 | -15 | -1 | 2 | -23 |
| Dividend income | 11 | 30 | 15 | 19 | 12 | 55 | 58 |
| Net result from financial instruments at fair value through P&L | 182 | 249 | 191 | 224 | 69 | 622 | 317 |
| Net realised result from available-for-sale assets | 51 | 52 | 45 | 8 | 26 | 148 | 181 |
| Net fee and commission income | 408 | 430 | 439 | 376 | 368 | 1 277 | 1 074 |
| Other net income | 4 | 47 | 77 | 101 | 59 | 128 | 157 |
| Total income | 1 896 | 1 980 | 1 946 | 1 903 | 1 727 | 5 822 | 5 308 |
| Operating expenses | -914 | -910 | -1 229 | -963 | -895 | -3 053 | -2 985 |
| Impairment | -31 | 71 | -8 | -73 | -28 | 32 | -127 |
| on loans and receivables on available-for-sale assets |
-15 -6 |
78 -2 |
-6 -1 |
-54 -4 |
-18 -7 |
57 -9 |
-71 -51 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | -11 | -5 | 0 | -15 | -3 | -16 | -5 |
| Share in results of associated companies and joint ventures | 8 | 3 | 5 | 5 | 9 | 16 | 22 |
| Result before tax | 959 | 1 144 | 715 | 871 | 814 | 2 818 | 2 218 |
| Income tax expense | -268 | -288 | -85 | -186 | -184 | -641 | -476 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Result after tax | 691 | 855 | 630 | 685 | 629 | 2 176 | 1 742 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 691 | 855 | 630 | 685 | 629 | 2 176 | 1 742 |
| Basic earnings per share (EUR) Diluted earnings per share (EUR) |
1.62 1.62 |
2.01 2.01 |
1.47 1.47 |
1.61 1.61 |
1.47 1.47 |
5.11 5.11 |
4.07 4.07 |
| Key consolidated balance sheet figures KBC Group (in millions of EUR) |
30-09-2017 | 30-06-2017 | 31-03-2017 | 31-12-2016 | 30-09-2016 |
|---|---|---|---|---|---|
| Total assets | 296 885 | 296 479 | 287 293 | 275 200 | 266 016 |
| Loans and advances to customers | 140 466 | 139 350 | 135 304 | 133 231 | 131 973 |
| Securities (equity and debt instruments) | 69 273 | 70 898 | 72 329 | 73 262 | 72 774 |
| Deposits from customers and debt certificates | 190 824 | 189 938 | 181 722 | 177 730 | 170 425 |
| Technical provisions, before reinsurance | 18 696 | 18 905 | 19 234 | 19 657 | 19 745 |
| Liabilities under investment contracts, insurance | 13 294 | 13 339 | 13 128 | 12 653 | 12 506 |
| Parent shareholders' equity | 17 003 | 16 665 | 16 506 | 15 957 | 15 135 |
| Selected ratios for the KBC group (consolidated) | 9M2017 | FY2016 | 9M2016 |
|---|---|---|---|
| Profitability and efficiency | |||
| Return on equity | 19% | 18% | 18% |
| Cost/income ratio, banking (between brackets: when evenly spreading the bank taxes and excluding certain non operating items) |
54% (54%) | 55% (57%) | 57% (57%) |
| Combined ratio, non-life insurance | 83% | 93% | 94% |
| Solvency | |||
| Common equity ratio according to Basel III Danish Compromise method (phased-in/fully loaded) | 16.1%/15.9% | 16.2%/15.8% | 15.1%/15.3% |
| Common equity ratio according to FICOD method (fully loaded) | 15.2% | 14.5% | 13.6% |
| Leverage ratio according to Basel III (fully loaded) | 5.8% | 6.1% | 6.2% |
| Credit risk | |||
| Credit cost ratio* | -0.05% | 0.09% | 0.07% |
| Impaired loans ratio | 6.6% | 7.2% | 7.6% |
| for loans more than 90 days overdue | 3.7% | 3.9% | 4.2% |
| Liquidity | |||
| Net stable funding ratio (NSFR) | 130% | 125% | 123% |
| Liquidity coverage ratio (LCR) | 150% | 139% | 137% |
* Negative figure indicates a net impairment release (with positive impact on results).
The net result for the quarter amounted to 691 million euros, compared to 855 million euros in the previous quarter and 629 million euros in the corresponding quarter a year earlier.
Note: the results of the recently acquired UBB and Interlease entities in Bulgaria are included in the group's results as of the third quarter of 2017 (net result of 14 million euros). Please note that UBB and Interlease were already included in the balance sheet at 30 June 2017.
Net interest income (1 039 million euros) was up 1% on its level in the previous quarter, but down 2% on its year-earlier level. Net interest income benefited from lower funding costs and continued loan volume growth – see below – and from the first-time inclusion of UBB/Interlease in the figures, which accounted for 28 million euros of net interest income. These positive items were offset in part by a more negative level of interest income generated by the dealing rooms, the continued effect of low reinvestment yields, lower prepayment fees on mortgage loan refinancing (mainly year-on-year) and loan margin pressure in most core countries. As a result, our net interest margin came to 1.83% for the quarter under review, down 3 and 7 basis points, respectively, on the figure recorded in the previous and year-earlier quarters. As already mentioned, interest income continued to be supported by loan volume growth: our total volume of lending rose by 1% quarter-onquarter and by 6% year-on-year, with growth in all business units. Deposits remained flat
quarter-on-quarter and went up 12% year-on-year with increases in all business units. Excluding UBB/Interlease, the year-onyear organic growth of loans would have been 4% and the year-on-year growth of deposits some 10%.
Technical income from our non-life and life insurance activities (earned premiums less technical charges, plus the ceded reinsurance result) stood at a high 201 million euros in the quarter under review. Non-life insurance activities contributed 202 million euros to this technical insurance income figure, 19% and 23% more than in the previous and year-earlier quarters, respectively, thanks to increased non-life premium income in almost all core countries, a higher reinsurance result and a one-off release of non-life provisions in Belgium (26 million euros). Consequently, our combined ratio for the first nine months of 2017 came to an exceptionally good 83% (86% excluding the one-off provisions release), compared to 93% for full year 2016. Technical insurance income from our life insurance activities stood at -1 million euros, an improvement on the -25 million euros recorded in the previous quarter and the -35 million euros posted in the year-earlier quarter, due to the fact that it also benefited from a release of life-related provisions in Belgium (23 million euros), among other things. Sales of life insurance products were 3% lower than in the previous quarter, and were down 10% on the year-earlier quarter, with most of the decline occurring in the sale of guaranteed interest products in Belgium (related to the low interest rate environment). Consequently, the share of guaranteed interest products in total sales of life insurance products dropped to 54% in the third quarter of 2017, with unit-linked products accounting for the remaining 46%.
Net fee and commission income – at 408 million euros – remained robust. Year-on-year, it was up 11%, thanks mainly to the contribution made by our asset management activities in Belgium, and, to a lesser extent, to higher payment service fees in a number of countries and to the first-time inclusion of UBB/Interlease in the figures (accounting for 12 million euros). Compared to the previous quarter, however, there was a decrease of 5% which partly reflects the effect of the holiday season (lower entry fees due to a drop in sales of funds and lower securities-related transactions, etc.). At the end of September 2017, our total assets under management stood at 217 billion euros, up 1% quarter-on-quarter and almost 4% year-on-year, due in both cases mainly to the positive price performance.
All other income items amounted to an aggregate 248 million euros, compared to 378 million euros in the previous quarter and 166 million euros in the year-earlier quarter. The figure for the third quarter of 2017 included a relatively high 51 million euros in gains realised on the sale of available-for-sale securities (predominantly on shares), 11 million euros in dividend income (down on the figure for the second quarter of 2017, when the bulk of dividends is usually received) and 4 million euros in other net income (down quarter-on-quarter and year-on-year since it includes an additional provision of 54 million euros related to an ongoing industry wide review of the tracker rate mortgage products originated in Ireland before 2009). It also included the 182-million-euro net result from financial instruments at fair value (trading and fair value income). The latter was up on the 69 million euros recorded in the year-earlier quarter, but down on the very high 249 million euros recorded in the previous quarter, due principally to the lower mark-to-market value change of derivatives used for asset/liability management purposes (partly related to CZK swaps) and a decrease in dealing room income.
At 914 million euros, operating expenses were flat quarter-on-quarter and up 2% year-on-year (disregarding UBB/Interlease, expenses were even down 2% quarter-on-quarter and flat year-on-year). The flat level of costs quarter-on-quarter – despite the 20-million-euro impact of UBB/Interlease – was attributable mainly to lower staff expenses, professional fees, facilities expenses and ICT costs, among other things. The 2% year-on-year increase in costs, on the other hand, resulted from an increase in staff expenditure (wage drift), ICT costs, depreciation and the impact of UBB/Interlease, partly offset by decreases in professional fees, facilities expenses and marketing costs.
As a result, the cost/income ratio of our banking activities stood at a solid 54% in the first nine months of 2017, compared to 55% for full year 2016. When the bank taxes are evenly spread throughout the year and certain non-operating items are excluded (mark-to-market of derivatives used for asset/liability management purposes, the impact of legacy legal cases, the effect of the liquidation of group companies, etc.), our adjusted cost/income ratio for the first nine months of 2017 also amounted to 54%, compared to 57% for full year 2016.
In the third quarter of 2017, there was only a very small increase in loan loss impairment (15 million). There had been a net impairment release (with a positive impact on the results) of 78 million euros in the previous quarter and an increase of 18 million euros in the year-earlier quarter. The low level of impairment in the quarter under review was attributable to the combination of a 26-million-euro impairment release in Ireland (which came about mainly because of the positive movement in the 9-month average house price index and an improvement in the portfolio of non-performing loans), and a relatively low level of additional impairment charges in all other core countries: 21 million euros in Belgium (quarter-on-quarter increase due to one large corporate loan), 1 million euros in the Czech Republic, 7 million euros in Slovakia, 0 million euros in Hungary, 7 million euros in Bulgaria (almost entirely relating to the UBB portfolio) and 6 million euros in the Group Centre.
Consequently, annualised loan loss impairment for the entire group in the first nine months of 2017 accounted for an extremely low -0.05% of the total loan portfolio (a negative figure indicates a positive impact on the results).
Loan quality improved further: at the end of September 2017, some 6.6% of our loan book was classified as impaired, with 3.7% being 'impaired and more than 90 days past due'. This compares with 7.2% and 3.9%, respectively, at year-end 2016.
Impairment on assets other than loans stood at 17 million euros, compared to 7 million in the previous quarter and 10 million euros in the third quarter of 2016. The figure for the third quarter of 2017 mainly related to available-for-sale shares, facilities assets and ICT, among other things.
Our quarterly profit of 691 million euros breaks down as follows:
455 million euros for the Belgium Business Unit.
The net result was down 6% quarter-on-quarter. This was due to a partly seasonal decline in net fee and commission income and dividend income, lower net interest income, a decrease in trading and fair value income following the very high level in the previous quarter, higher – but still low – loan loss impairment and an increase in impairment on other assets. This was offset by a number of items, including significantly better technical insurance income (thanks in part to one-off releases of provisions), increased other net income, and lower operating expenses.
170 million euros for the Czech Republic Business Unit.
The net result was down 7% on its level for the previous quarter, essentially due to trading and fair value income, which – though still high – was lower than the very high level recorded in the previous quarter. Other significant items were a lower level of realised gains on the sale of financial assets and a decrease in fee and commission income, partly offset by a lower level of loan loss impairment and improved technical insurance income.
78 million euros for the International Markets Business Unit, 16 million euros of which was accounted for by Slovakia, 40 million euros by Hungary, 22 million euros by Bulgaria (including 14 million euros at UBB/Interlease) and -1 million euros by Ireland. For the business unit as a whole, this represented a quarter-on-quarter decrease of 99 million euros, which was primarily attributable to Ireland, where loan loss impairment releases were lower in the quarter under review and a provision of 54 million euros was set aside relating to an ongoing industry wide review of the tracker rate mortgage products originated in Ireland
-12 million euros for the Group Centre. This is 24 million euros down on the level recorded in the previous quarter, largely situated in trading and fair value income.
| Belgium | Czech Republic | International Markets | ||||||
|---|---|---|---|---|---|---|---|---|
| Selected ratios per business unit | 9M2017 | FY2016 | 9M2017 | FY2016 | 9M2017 | FY2016 | ||
| Cost/income ratio, banking (between brackets: when evenly spreading bank taxes and excl. certain non-operating items) |
53% (52%) | 54% (55%) | 41% (42%) | 45% (46%) | 68% (67%) | 64% (66%) | ||
| Combined ratio, non-life insurance | 80% | 92% | 97% | 96% | 92% | 94% | ||
| Credit cost ratio* | 0.10% | 0.12% | 0.04% | 0.11% | -0.74% | -0.16% | ||
| Impaired loans ratio | 2.8% | 3.3% | 2.5% | 2.8% | 22.4% | 25.4% |
* Negative figure indicates a net impairment release (with positive impact on results).
before 2009.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
At the end of September 2017, our total equity stood at 18.4 billion euros (17.0 billion euros in parent shareholders' equity and 1.4 billion euros in additional tier-1 instruments), up 1.0 billion euros on its level at the beginning of the year. The change during the first nine months of the year resulted from the inclusion of the profit for that period (+2.2 billion euros), the payout of the final dividend for 2016 in May and the decision to pay an interim dividend for 2017 in November (an aggregate -1.2 billion euros), changes in the available-for-sale and cash flow hedge reserves (-0.1 and +0.2 billion euros, respectively) and a number of minor items.
At 30 September 2017, our fully loaded common equity ratio (Basel III, under the Danish compromise) stood at a strong 15.9%. Our leverage ratio (Basel III, fully loaded) came to 5.8%. The solvency ratio for KBC Insurance under the Solvency II framework was a sound 221% at 30 September 2017.
Our liquidity position remained excellent too, as reflected in an LCR ratio of 150% and an NSFR ratio of 130% at the end of September 2017.
The net result for the first nine months 2017 amounted to 2 176 million euros, compared to 1 742 million euros in the corresponding period of 2016.
Note: the result for the first nine months of 2017 includes the net result of 14 million euros generated by the recently acquired UBB and Interlease entities in Bulgaria in the period July through September.
Highlights (compared to 9M2016):
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. Although we closely monitor and manage each of these risks within a strict risk framework containing governance and limits, they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector in general and, as a consequence, are also relevant to us. Regulatory uncertainty regarding capital requirements is a dominant theme for the sector, besides enhanced consumer protection. Another ongoing challenge remains the low interest rate environment, despite the recent uptrend, particularly for longer maturities, combined with the increased risk of asset bubbles. The financial sector also faces the potential systemic consequences of political and financial developments like Brexit or protectionist measures in the US, which will have an impact on the European economy. EU political risks receded earlier this year following the outcome of the Dutch and French elections, but the situation in Catalonia might develop into a new source of uncertainty. In addition, concerns remain on the banking sector in certain countries. Financial technology is an additional challenge for the business model of traditional financial institutions. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
On the macroeconomic front, the strong momentum of global economic growth continued in the third quarter of 2017. This favourable environment allowed the Fed to start its balance sheet normalisation programme at the beginning of October. Economic growth in the euro area remained well above its long-term potential rate, leading to further improvements on the European labour market. Oil prices rose during the third quarter, which caused a modest increase in headline inflation compared to its second quarter level. Core inflation, however, remained broadly stable at a low level. Both the US and German long-term government bond yields ended the third quarter virtually unchanged at low levels. Meanwhile, intra-EMU sovereign yield spreads remained generally stable, with the notable exception of Spain (slightly higher due to political events in Catalonia), and Portugal (significantly lower due to its sovereign debt rating being upgraded). On balance, the strong economic performance in the euro area caused the euro to appreciate markedly against the US dollar. The euro peaked at the end of August, before depreciating again somewhat as a result of the Fed's determination to pursue its normalisation path.
Risk management data is provided in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
Our view on interest rates and foreign exchange rates: the ECB will continue its QE programme until at least September 2018. From January 2018 on, the volume of these net monthly purchases will be reduced to 30 billion euros. The ECB will only raise its policy rate in 2019. In the meantime, we expect the Fed to carry out another policy rate hike in 2017 and three more in 2018 (each time by 25 basis points). Consequently, we believe that the US dollar will appreciate against the euro in 2017 and in early 2018, as it will benefit from short-term interest rate support. The euro will start appreciating again after this period. Given the low inflation environment and still highly accommodating global monetary policies, German and US long-term bond yields are expected to rise only modestly in the period ahead. Unlike the dovish stance of the ECB, the Czech National Bank has already begun to tighten its monetary policy and is expected to continue to do so in the coming year. We forecast two more rate hikes for next year so that the repo rate will be at 1% by the end of 2018. However, given the economic and inflationary developments together with possible fiscal stimulus by the new government, a more aggressive policy is possible.
Our view on economic growth: the economic environment in the euro area is favourable and, as a result, the consumer sector remains solid. The unemployment rate is steadily falling, which will further support consumption in the period ahead. The most significant risks continue to stem from the trend of de-globalisation and from geopolitical concerns, which could create additional uncertainty and hence affect economic sentiment.
Notice to the holders of the 1 billion USD contingent capital note ('CoCo') of KBC Bank NV:
we intend to call the CoCo in January 2018. Hence, the capital value of the CoCo has already been excluded from Tier-2 capital. The impact of calling the CoCo has largely been offset by the successful issue of a 500-million-euro tier-2 benchmark in September 2017.
We repeat our guidance:
KBC Group Consolidated financial statements according to IFRS 3Q 2017 and 9M 2017
Section reviewed by the Auditor
| (in millions of EUR) | Note | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 3 091 | 3 201 | 1 039 | 1 028 | 1 064 |
| Interest income | 3.1 | 4 747 | 5 048 | 1 605 | 1 566 | 1 673 |
| Interest expense | 3.1 | - 1 655 | - 1 847 | - 566 | - 538 | - 609 |
| Non-life insurance before reinsurance | 3.7 | 554 | 450 | 188 | 179 | 164 |
| Earned premiums Non-life | 3.7 | 1 107 | 1 047 | 378 | 369 | 357 |
| Technical charges Non-life | 3.7 | - 553 | - 597 | - 190 | - 190 | - 193 |
| Life insurance before reinsurance | 3.7 | - 55 | - 107 | - 3 | - 24 | - 34 |
| Earned premiums Life | 3.7 | 861 | 1 163 | 282 | 267 | 336 |
| Technical charges Life | 3.7 | - 916 | - 1 271 | - 284 | - 291 | - 370 |
| Ceded reinsurance result | 3.7 | 2 | - 23 | 16 | - 10 | - 1 |
| Dividend income | 3.2 | 55 | 58 | 11 | 30 | 12 |
| Net result from financial instruments at fair value through profit or loss | 3.3 | 622 | 317 | 182 | 249 | 69 |
| Net realised result from available-for-sale assets | 3.4 | 148 | 181 | 51 | 52 | 26 |
| Net fee and commission income | 3.5 | 1 277 | 1 074 | 408 | 430 | 368 |
| Fee and commission income | 3.5 | 1 974 | 1 549 | 606 | 748 | 525 |
| Fee and commission expense | 3.5 | - 697 | - 475 | - 198 | - 318 | - 157 |
| Net other income | 3.6 | 128 | 157 | 4 | 47 | 59 |
| TOTAL INCOME | 5 822 | 5 308 | 1 896 | 1 980 | 1 727 | |
| Operating expenses | 3.8 | - 3 053 | - 2 985 | - 914 | - 910 | - 895 |
| Staff expenses | 3.8 | - 1 719 | - 1 671 | - 578 | - 577 | - 560 |
| General administrative expenses | 3.8 | - 1 137 | - 1 131 | - 268 | - 269 | - 272 |
| Depreciation and amortisation of fixed assets | 3.8 | - 197 | - 183 | - 68 | - 65 | - 62 |
| Impairment | 3.10 | 32 | - 127 | - 31 | 71 | - 28 |
| on loans and receivables | 3.10 | 57 | - 71 | - 15 | 78 | - 18 |
| on available-for-sale assets | 3.10 | - 9 | - 51 | - 6 | - 2 | - 7 |
| on goodwill | 3.10 | 0 | 0 | 0 | 0 | 0 |
| on other | 3.10 | - 16 | - 5 | - 11 | - 5 | - 3 |
| Share in results of associated companies and joint ventures | 3.11 | 16 | 22 | 8 | 3 | 9 |
| RESULT BEFORE TAX | 2 818 | 2 218 | 959 | 1 144 | 814 | |
| Income tax expense | 3.12 | - 641 | - 476 | - 268 | - 288 | - 184 |
| RESULT AFTER TAX | 2 176 | 1 742 | 691 | 855 | 629 | |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | |
| Attributable to equity holders of the parent | 2 176 | 1 742 | 691 | 855 | 629 | |
| Earnings per share (in EUR) | ||||||
| Basic | 3.13 | 5,11 | 4,07 | 1,62 | 2,01 | 1,47 |
| Diluted | 3.13 | 5,11 | 4,07 | 1,62 | 2,01 | 1,47 |
Impact acquisition UBB/Interlease:
UBB/Interlease are included in the consolidated income statement as of 3Q 2017.
For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| (in millions of EUR) | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 2 176 | 1 742 | 691 | 855 | 629 |
| attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 2 176 | 1 742 | 691 | 855 | 629 |
| Other comprehensive income - to be recycled to P&L | 27 | - 250 | 49 | 84 | 168 |
| Net change in revaluation reserve (AFS assets) - Equity | - 19 | - 142 | - 14 | - 42 | 62 |
| Net change in revaluation reserve (AFS assets) - Bonds | - 115 | 401 | 54 | 45 | 129 |
| Net change in revaluation reserve (AFS assets) - Other | 0 | 0 | 0 | 0 | 0 |
| Net change in hedging reserve (cash flow hedge) | 182 | - 506 | 22 | 80 | - 35 |
| Net change in translation differences | - 17 | - 18 | - 12 | - 3 | - 4 |
| Net change related to associated companies & joint ventures | - 3 | 3 | - 1 | 5 | 3 |
| Other movements | - 1 | 11 | 0 | - 1 | 12 |
| Other comprehensive income - not to be recycled to P&L | 58 | - 312 | 31 | - 11 | - 65 |
| Net change in defined benefit plans | 63 | - 312 | 30 | - 8 | - 65 |
| Net change on own credit risk - liabilities designated at FV(T)PL | - 5 | 0 | 1 | - 3 | 0 |
| Net change related to associated companies & joint ventures | 0 | 0 | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 2 261 | 1 181 | 771 | 928 | 732 |
| attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 2 260 | 1 181 | 771 | 928 | 732 |
The largest movements in other comprehensive income (9M 2017 vs. 9M 2016):
| ASSETS (in millions of EUR) | Note | 30-09-2017 | 31-12-2016 |
|---|---|---|---|
| Cash, cash balances at central banks and other demand deposits | - | 37 738 | 20 686 |
| Financial assets | 4.1 - 4.7 | 251 078 | 246 298 |
| Held for trading | 4.1 - 4.7 | 8 390 | 9 683 |
| Designated at fair value through profit or loss | 4.1 - 4.7 | 14 367 | 14 184 |
| Available for sale | 4.1 - 4.7 | 35 421 | 36 708 |
| Loans and receivables | 4.1 - 4.7 | 161 702 | 151 615 |
| Held to maturity | 4.1 - 4.7 | 30 834 | 33 697 |
| Hedging derivatives | 4.1 - 4.7 | 365 | 410 |
| Reinsurers' share in technical provisions | 5.6 | 137 | 110 |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | - | - 68 | 202 |
| Tax assets | 5.2 | 2 064 | 2 312 |
| Current tax assets | 5.2 | 77 | 66 |
| Deferred tax assets | 5.2 | 1 986 | 2 246 |
| Non-current assets held for sale and assets associated with disposal groups | - | 31 | 8 |
| Investments in associated companies and joint ventures | 5.2 | 223 | 212 |
| Investment property | 5.4 | 463 | 426 |
| Property and equipment | 5.4 | 2 548 | 2 451 |
| Goodwill and other intangible assets | 5.5 | 1 164 | 999 |
| Other assets | 5.1 | 1 507 | 1 496 |
| TOTAL ASSETS | 296 885 | 275 200 | |
| LIABILITIES AND EQUITY (in millions of EUR) | Note | 30-09-2017 | 31-12-2016 |
| Financial liabilities | 4.1 - 4.7 | ||
| 255 619 | 234 300 | ||
| Held for trading | 4.1 - 4.7 | 6 944 | 8 559 |
| Designated at fair value through profit or loss | 4.1 - 4.7 | 15 058 | 16 553 |
| Measured at amortised cost | 4.1 - 4.7 | 232 127 | 207 485 |
| Hedging derivatives | 4.1 - 4.7 | 1 490 | 1 704 |
| Technical provisions, before reinsurance | 5.6 | 18 696 | 19 657 |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | - | - 5 | 204 |
| Tax liabilities | 5.2 | 714 | 681 |
| Current tax liabilities | 5.3 | 202 | 188 |
| Deferred tax liabilies | 5.4 | 512 | 493 |
| Provisions for risks and charges | 5.7 | 344 | 238 |
| Other liabilities | 5.8 | 3 113 | 2 763 |
| TOTAL LIABILITIES | 278 482 | 257 843 | |
| Total equity | 5.10 | 18 403 | 17 357 |
| Parent shareholders' equity | 5.10 | 17 003 | 15 957 |
| Additional Tier-1 instruments included in equity | 5.10 | 1 400 | 1 400 |
| Minority interests | - | 0 | 0 |
| TOTAL LIABILITIES AND EQUITY | 296 885 | 275 200 |
In order to align with the consolidated financial reporting framework (FINREP) of the European Banking Authority, the presentation of the balance sheet has been slightly changed: Cash and cash balances includes as of 2017 also other demand deposits with credit institutions and consequently has been renamed 'Cash, cash balances at central banks and other demand deposits from credit institutions'. The reference figures have been restated accordingly (shift of 538 million euros mainly from Loans and receivables).
The balance sheet of 30 September 2017 includes UBB/Interlease: for more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| Additional | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hedging | Remeasurement | Own credit | Tier-1 | ||||||||||
| Revaluation | reserve | of defined | risk | instruments | |||||||||
| Issued and paid | Share | Treasury | reserve | (cashflow | benefit | (through | Retained | Translation | Parent share | included in | Minority | Total | |
| In millions of EUR | up share capital | premium | shares | (AFS assets) | hedges) | obligations | OCI) | earnings | differences | holders' equity | equity | interests | equity |
| 30-09-2017 | |||||||||||||
| Balance at the beginning of the period (01-01-2017) | 1 455 | 5 453 | 0 | 1 756 | - 1 347 | - 138 | - 4 | 8 751 | 31 | 15 957 | 1 400 | 0 | 17 357 |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 176 | 0 | 2 176 | 0 | 0 | 2 176 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 143 | 182 | 63 | - 5 | - 1 | - 11 | 84 | 0 | 0 | 84 |
| Total comprehensive income | 0 | 0 | 0 | - 143 | 182 | 63 | - 5 | 2 175 | - 11 | 2 260 | 0 | 0 | 2 261 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 171 | 0 | - 1 171 | 0 | 0 | - 1 171 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 39 | 0 | - 39 | 0 | 0 | - 39 |
| Purchases of treasury shares | 0 | 0 | - 5 | 0 | 0 | 0 | 0 | 0 | 0 | - 5 | 0 | 0 | - 5 |
| Total change | 0 | 0 | - 5 | - 143 | 182 | 63 | - 5 | 965 | - 11 | 1 046 | 0 | 0 | 1 046 |
| Balance at the end of the period | 1 455 | 5 453 | - 5 | 1 613 | - 1 165 | - 75 | - 9 | 9 716 | 20 | 17 003 | 1 400 | 0 | 18 403 |
| of which revaluation reserve for shares of which revaluation reserve for bonds |
472 1 141 |
||||||||||||
| of which relating to equity method | 16 | 0 | 0 | 0 | 0 | 13 | 29 | 29 |
| 30-09-2016 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at the beginning of the period (01-01-2016) | 1 454 | 5 437 | 0 | 1 782 | - 1 146 | 94 | 0 | 6 779 | 11 | 14 411 | 1 400 | 0 | 15 811 |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 742 | 0 | 1 742 | 0 | 0 | 1 742 |
| Other comprehensive income for the period | 0 | 0 | 0 | 263 | - 506 | - 312 | 0 | 11 | - 18 | - 561 | 0 | 0 | - 561 |
| Total comprehensive income | 0 | 0 | 0 | 263 | - 506 | - 312 | 0 | 1 754 | - 18 | 1 181 | 0 | 0 | 1 181 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 418 | 0 | - 418 | 0 | 0 | - 418 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 39 | 0 | - 39 | 0 | 0 | - 39 |
| Total change | 0 | 0 | 0 | 263 | - 506 | - 312 | 0 | 1 296 | - 18 | 723 | 0 | 0 | 723 |
| Balance at the end of the period | 1 454 | 5 437 | 0 | 2 045 | - 1 652 | - 218 | 0 | 8 075 | - 7 | 15 135 | 1 400 | 0 | 16 534 |
| of which revaluation reserve for shares | 405 | ||||||||||||
| of which revaluation reserve for bonds | 1 640 | ||||||||||||
| of which relating to equity method | 25 | 0 | 0 | 0 | 7 | 32 | 32 |
As an advance payment of the total 2016 dividend, KBC decided to distribute an interim dividend of 1 euro per share (418 million euros in total), paid on 18 November 2016 (already deducted from retained earnings in 3Q 2016).
Furthermore, for 2016 the board of directors proposed to the general meeting of shareholders, who approved this on 4 May 2017, that a closing dividend of 1.80 euros is paid out per share entitled to dividend (753 million euros in total). This dividend is deducted from retained earnings and was accounted for in 2Q 2017.
In line with our dividend policy, the Board of 9 August 2017 has decided to pay an interim dividend of 1 euro per share (418 million euros in total), as an advance payment on the total dividend (payment date 17 November 2017) (already deducted from retained earnings in 3Q 2017).
| In millions of EUR | 9M 2017 | 9M 2016 |
|---|---|---|
| Cash and cash equivalents at the beginning of the period | 26 747 | 10 987 |
| Net cash from (used in) operating activities | 14 857 | 9 413 |
| Net cash from (used in) investing activities | 2 973 | 345 |
| Net cash from (used in) financing activities | - 359 | - 1 259 |
| Effects of exchange rate changes on opening cash and cash equivalents | 416 | 10 |
| Cash and cash equivalents at the end of the period | 44 633 | 19 496 |
Cash and cash equivalents increased substantially in 9M 2017 mainly thanks to the higher amount of reverse repos and cash balances at central banks. This was largely generated out of net cash from operating activities thanks to higher deposits.
Impact acquisition UBB/Interlease: for more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
The condensed interim financial statements of the KBC Group for the first 9 months ended 30 September 2017 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2016, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The same accounting policies, methods of computation and presentation have been followed in its preparation as were applied in the most recent annual financial statements, except for the following items:
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2016.
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2016.
| Business | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| unit | |||||||||
| Business | Business | Interna | |||||||
| unit | unit Czech | tional | of which: | of which: | of which: | of which: | Group | KBC | |
| In millions of EUR | Belgium | Republic | Markets | Hungary | Slovakia | Bulgaria | Ireland | Centre | Group |
| 9M 2017 | |||||||||
| Net interest income | 1 825 | 654 | 609 | 181 | 158 | 65 | 206 | 3 | 3 091 |
| Non-life insurance before reinsurance | 426 | 65 | 56 | 27 | 18 | 11 | 0 | 7 | 554 |
| Earned premiums Non-life | 777 | 157 | 166 | 74 | 27 | 66 | 0 | 6 | 1 107 |
| Technical charges Non-life | - 351 | - 93 | - 110 | - 47 | - 8 | - 55 | 0 | 0 | - 553 |
| Life insurance before reinsurance | - 108 | 35 | 18 | 5 | 9 | 3 | 0 | 1 | - 55 |
| Earned premiums Life | 635 | 164 | 62 | 12 | 36 | 14 | 0 | 0 | 861 |
| Technical charges Life | - 743 | - 129 | - 44 | - 7 | - 26 | - 11 | 0 | 1 | - 916 |
| Ceded reinsurance result | - 5 | - 6 | 11 | - 1 | - 1 | 14 | 0 | 2 | 2 |
| Dividend income | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 55 |
| Net result from financial instruments at fair value through profit or loss | 390 | 169 | 72 | 47 | 12 | 8 | 5 | - 9 | 622 |
| Net realised result from available-for-sale assets | 89 | 16 | 3 | 2 | 0 | 1 | 0 | 39 | 148 |
| Net fee and commission income | 977 | 138 | 166 | 118 | 38 | 8 | - 1 | - 5 | 1 277 |
| Net other income | 136 | 36 | - 52 | 0 | 6 | - 4 | - 55 | 8 | 128 |
| TOTAL INCOME | 3 775 | 1 107 | 885 | 380 | 240 | 107 | 155 | 55 | 5 822 |
| Operating expenses | - 1 886 | - 469 | - 601 | - 260 | - 148 | - 62 | - 130 | - 97 | - 3 053 |
| Impairment | - 92 | - 13 | 150 | 9 | - 9 | - 11 | 162 | - 13 | 32 |
| on loans and receivables | - 75 | - 7 | 152 | 10 | - 9 | - 11 | 162 | - 13 | 57 |
| on available-for-sale assets | - 8 | 0 | - 1 | 0 | 0 | - 1 | 0 | 0 | - 9 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| on other | - 9 | - 6 | - 1 | - 1 | 0 | 0 | 0 | 0 | - 16 |
| Share in results of associated companies and joint ventures | - 4 | 17 | 4 | 0 | 0 | 1 | 0 | 0 | 16 |
| RESULT BEFORE TAX | 1 793 | 642 | 438 | 129 | 82 | 35 | 188 | - 55 | 2 818 |
| Income tax expense | - 553 | - 108 | - 68 | - 22 | - 19 | - 3 | - 23 | 88 | - 641 |
| RESULT AFTER TAX | 1 240 | 534 | 370 | 107 | 63 | 31 | 164 | 32 | 2 176 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NET RESULT | 1 240 | 534 | 370 | 107 | 63 | 31 | 164 | 32 | 2 176 |
| 9M 2016 | |||||||||
| Net interest income | 2 050 | 634 | 542 | 172 | 160 | 36 | 174 | - 25 | 3 201 |
| Non-life insurance before reinsurance | 319 | 55 | 68 | 24 | 15 | 28 | 0 | 9 | 450 |
| Earned premiums Non-life | 755 | 140 | 146 | 61 | 24 | 61 | 0 | 7 | 1 047 |
| Technical charges Non-life | - 436 | - 85 | - 78 | - 36 | - 9 | - 34 | 0 | 3 | - 597 |
| Technical charges Non-life | - 436 | - 85 | - 78 | - 36 | - 9 | - 34 | 0 | 3 | - 597 |
|---|---|---|---|---|---|---|---|---|---|
| Life insurance before reinsurance | - 146 | 26 | 13 | 1 | 9 | 3 | 0 | 0 | - 107 |
| Earned premiums Life | 919 | 177 | 68 | 12 | 39 | 17 | 0 | 0 | 1 163 |
| Technical charges Life | - 1 065 | - 151 | - 54 | - 11 | - 30 | - 14 | 0 | 0 | - 1 271 |
| Ceded reinsurance result | - 3 | - 1 | - 4 | - 1 | - 1 | - 1 | 0 | - 15 | - 23 |
| Dividend income | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 58 |
| Net result from financial instruments at fair value through profit or loss | 155 | 93 | 65 | 51 | 13 | 1 | 0 | 4 | 317 |
| Net realised result from available-for-sale assets | 84 | 48 | 36 | 18 | 15 | 3 | 0 | 13 | 181 |
| Net fee and commission income | 790 | 141 | 151 | 117 | 34 | - 3 | 0 | - 8 | 1 074 |
| Net other income | 142 | 16 | - 3 | 0 | 3 | - 4 | - 3 | 3 | 157 |
| TOTAL INCOME | 3 437 | 1 011 | 868 | 383 | 248 | 64 | 171 | - 7 | 5 308 |
| Operating expenses | - 1 876 | - 457 | - 561 | - 256 | - 144 | - 41 | - 117 | - 91 | - 2 985 |
| Impairment | - 119 | - 13 | 31 | 12 | - 8 | - 4 | 31 | - 27 | - 127 |
| on loans and receivables | - 67 | - 12 | 34 | 14 | - 8 | - 4 | 32 | - 27 | - 71 |
| on available-for-sale assets | - 51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 51 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| on other | - 1 | - 1 | - 3 | - 2 | 0 | 0 | - 1 | 0 | - 5 |
| Share in results of associated companies and joint ventures | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 3 | 22 |
| RESULT BEFORE TAX | 1 442 | 560 | 338 | 139 | 95 | 18 | 85 | - 121 | 2 218 |
| Income tax expense | - 448 | - 95 | - 49 | - 32 | - 19 | - 2 | 4 | 117 | - 476 |
| RESULT AFTER TAX | 994 | 465 | 289 | 106 | 76 | 16 | 89 | - 5 | 1 742 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NET RESULT | 993 | 465 | 289 | 106 | 76 | 16 | 89 | - 5 | 1 742 |
| In millions of EUR | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| Total | 3 091 | 3 201 | 1 039 | 1 028 | 1 064 |
| Interest income | 4 747 | 5 048 | 1 605 | 1 566 | 1 673 |
| Available-for-sale assets | 492 | 532 | 165 | 161 | 180 |
| Loans and receivables | 2 854 | 2 869 | 976 | 957 | 949 |
| Held-to-maturity investments | 645 | 732 | 207 | 203 | 243 |
| Other assets not at fair value | 119 | 61 | 45 | 41 | 21 |
| Subtotal, interest income from financial assets not measured at fair value through | |||||
| profit or loss | 4 110 | 4 193 | 1 393 | 1 363 | 1 393 |
| Financial assets held for trading | 440 | 520 | 145 | 143 | 168 |
| Hedging derivatives | 192 | 220 | 65 | 59 | 67 |
| Other financial assets at fair value through profit or loss | 4 | 116 | 2 | 1 | 44 |
| Interest expense | -1 655 | -1 847 | - 566 | - 538 | - 609 |
| Financial liabilities measured at amortised cost | - 714 | - 674 | - 249 | - 237 | - 221 |
| Other | - 68 | - 12 | - 28 | - 22 | - 8 |
| Subtotal, interest expense for financial liabilities not measured at fair value | |||||
| through profit or loss | - 781 | - 686 | - 277 | - 259 | - 228 |
| Financial liabilities held for trading | - 488 | - 596 | - 154 | - 163 | - 191 |
| Hedging derivatives | - 358 | - 432 | - 126 | - 107 | - 141 |
| Other financial liabilities at fair value through profit or loss | - 23 | - 128 | - 7 | - 8 | - 47 |
| Net interest expense on defined benefit plans | - 5 | - 4 | - 2 | - 2 | - 1 |
The result from financial instruments at fair value through profit or loss in 3Q 2017 is 66 million euros lower compared to 2Q 2017. The quarter-on-quarter decrease is due to:
Compared to 3Q 2016, the result from financial instruments at fair value through profit or loss is 113 million euros higher in 3Q 2017, for a large part explained by:
The result from financial instruments at fair value through profit or loss in 9M 2017 is 305 million euros higher compared to 9M 2016, for a large part explained by:
| In millions of EUR | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| Total | 148 | 181 | 51 | 52 | 26 |
| Breakdown by portfolio | |||||
| Fixed-income securities | 24 | 21 | 2 | 8 | 14 |
| Shares | 124 | 159 | 49 | 44 | 11 |
| In millions of EUR | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| Total | 1 277 | 1 074 | 408 | 430 | 368 |
| Income | 1 974 | 1 549 | 606 | 748 | 525 |
| Expense | - 697 | - 475 | - 198 | - 318 | - 157 |
| Breakdown by type | |||||
| Asset Management Services | 931 | 743 | 295 | 314 | 261 |
| Income | 973 | 770 | 308 | 331 | 270 |
| Expense | - 41 | - 27 | - 13 | - 18 | - 9 |
| Banking Services | 561 | 537 | 187 | 190 | 176 |
| Income | 957 | 738 | 283 | 407 | 251 |
| Expense | - 397 | - 202 | - 96 | - 217 | - 75 |
| Distribution | - 215 | - 206 | - 74 | - 73 | - 70 |
| Income | 44 | 41 | 15 | 10 | 12 |
| Expense | - 259 | - 247 | - 89 | - 83 | - 82 |
Presentation change to the note Net fee and commission income: in view of a more transparent breakdown of the net fee and commission income, the following breakdown is provided as of 2017 (reference figures restated accordingly):
In 2Q 2017, within banking services, both the fee and commission income as well as the expense were inflated due to stock lending:
| In millions of EUR | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| Total | 128 | 157 | 4 | 47 | 59 |
| Of which net realised result following | |||||
| The sale of loans and receivables | 2 | 1 | 0 | 0 | 1 |
| The sale of held-to-maturity investments | 2 | 3 | 0 | - 4 | 2 |
| The repurchase of financial liabilities measured at amortised cost | 0 | - 7 | 0 | 0 | 0 |
| Other: of which: | 124 | 161 | 4 | 51 | 57 |
| Income concerning leasing at the KBC Lease-group | 59 | 59 | 19 | 20 | 20 |
| Income from Group VAB | 49 | 53 | 13 | 18 | 15 |
| Tracker mortgage review provision | - 54 | - 4 | - 54 | 0 | - 4 |
| Legal interests | 5 | 0 | 5 | 0 | 0 |
| One-off fee paid (Bulgaria) | - 5 | 0 | - 5 | 0 | 0 |
| Settlement of an old legal file (Czech Republic) | 14 | 0 | 0 | 0 | 0 |
In 3Q 2017, an additional 54 million euros provision were booked related to an ongoing industry wide review of legacy issues associated with tracker rate mortgage products in Ireland.
Like all major lenders in Ireland, KBC Ireland offered tracker mortgage loans. In KBC Ireland, these were available between 2003 and 2008.
In a prior review concluded in 2010, KBC Ireland identified 571 customers that would have moved from a fixed rate mortgage to a standard variable rate, but based on a review of their individual circumstances, the bank concluded that these customers should return to a tracker rate following the fixed rate period. These customers had their accounts amended prior to the expiry of the fixed rate period so they then correctly rolled to a tracker product.
Under the current Tracker Examination, KBC Ireland has so far identified an additional 490 impacted customers that did not move to a tracker rate after a fixed rate period or were moved off their tracker rate following a change to the terms of their loan or are on the incorrect tracker rate. As part of the ongoing review and within the Tracker Examination, KBC Ireland continues to examine tracker mortgage customer files and as a result anticipates that up to an additional 200 to 600 customers may be impacted. KBC Ireland expects to have concluded the identification of the vast majority of customers impacted by the Tracker Examination by year end. As such an additional 54 million euros provision were booked in 3Q 2017.
| Non-technical | ||||
|---|---|---|---|---|
| In millions of EUR | Life | Non-life | account | TOTAL |
| 9M 2017 | ||||
| Earned premiums, insurance (before reinsurance) | 862 | 1 122 | 1 985 | |
| Technical charges, insurance (before reinsurance) | - 916 | - 553 | - 1 470 | |
| Net fee and commission income | - 10 | - 216 | - 226 | |
| Ceded reinsurance result | 2 | 1 | 2 | |
| Operating expenses | - 106 | - 184 | - 2 | - 292 |
| Internal costs claim paid | - 6 | - 43 | - 49 | |
| Administration costs related to acquisitions | - 23 | - 55 | - 78 | |
| Administration costs | - 76 | - 86 | - 163 | |
| Management costs investments | 0 | 0 | - 2 | - 2 |
| Technical result | - 168 | 169 | - 2 | 0 |
| Net interest income | 428 | 428 | ||
| Dividend income | 33 | 33 | ||
| Net result from financial instruments at fair value | - 3 | - 3 | ||
| Net realised result from AFS assets | 63 | 63 | ||
| Net other income | - 10 | - 10 | ||
| Impairments | - 9 | - 9 | ||
| Allocation to the technical accounts | 404 | 68 | - 472 | 0 |
| Technical-financial result | 236 | 238 | 28 | 502 |
| Share in results of associated companies and joint ventures | 3 | 3 | ||
| RESULT BEFORE TAX | 236 | 238 | 31 | 505 |
| Income tax expense | - 145 | |||
| RESULT AFTER TAX | 360 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 360 | |||
| 9M 2016 | ||||
| Earned premiums, insurance (before reinsurance) | 1 165 | 1 062 | 2 227 | |
| Technical charges, insurance (before reinsurance) | - 1 271 | - 597 | - 1 868 | |
| Net fee and commission income | - 25 | - 202 | - 227 | |
| Ceded reinsurance result | - 1 | - 22 | - 23 | |
| Operating expenses | - 102 | - 183 | - 2 | - 287 |
| Internal costs claim paid | - 6 | - 43 | - 49 | |
| Administration costs related to acquisitions | - 24 | - 62 | - 86 | |
| Administration costs | - 72 | - 78 | - 150 | |
| Management costs investments | 0 | 0 | - 2 | - 2 |
| Technical result | - 234 | 58 | - 2 | - 178 |
| Net interest income | 467 | 467 | ||
| Dividend income | 39 | 39 | ||
| Net result from financial instruments at fair value | - 10 | - 10 | ||
| Net realised result from AFS assets | 50 | 50 | ||
| Net other income | 0 | 0 | ||
| Impairments | - 52 | - 52 | ||
| Allocation to the technical accounts | 415 | 53 | - 468 | 0 |
| Technical-financial result | 181 | 111 | 24 | 316 |
| Share in results of associated companies and joint ventures | 3 | 3 | ||
| RESULT BEFORE TAX | 181 | 111 | 27 | 319 |
| Income tax expense | - 103 | |||
| RESULT AFTER TAX | 216 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 217 |
Note: Figures for premiums exclude the investment contracts without DPF, which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2016 annual accounts).
The technical charges Non-Life include in 3Q 2017 the release the indexation provision for 26 million euros (before tax). More info, see note 1.1.
The technical charges Life in 3Q 2017 include a positive impact of a release of a specific Life reserve (the so-called flashing light reserve in Belgium) for an amount of +23 million euros (before tax). This reserve covers the interest rate risk resulting from the difference between the high guaranteed interest rate and a prescribed interest rate, which is based on the 5-year historic average of the 10Y OLO. As the contracts with a guaranteed interest rate above this prescribed interest rate reach maturity, the need for this reserve declines and as such the reserve can be reduced in line with the run-off of these insurance contracts.
The operating expenses for 3Q 2017 include 18 million euros related to bank (and insurance) levies (19 million euros in 2Q 2017; 24 million euros in 3Q 2016; 398 million euros in 9M 2017 and 410 million euros in 9M 2016). Application of IFRIC 21 (Levies) has as a consequence that a large part of the levies are taken upfront in expense of the first quarter of the year.
| In millions of EUR | 9M 2017 | 9M 2016 | 3Q 2017 | 2Q 2017 | 3Q 2016 |
|---|---|---|---|---|---|
| Total | 32 | - 127 | - 31 | 71 | - 28 |
| Impairment on loans and receivables | 57 | - 71 | - 15 | 78 | - 18 |
| Breakdown by type | |||||
| Specific impairments for on-balance-sheet lending | 88 | - 30 | 5 | 63 | 3 |
| Provisions for off-balance-sheet credit commitments | - 58 | 4 | - 31 | 5 | - 3 |
| Portfolio-based impairments | 27 | - 45 | 11 | 10 | - 18 |
| Breakdown by business unit | |||||
| Business unit Belgium | - 75 | - 67 | - 21 | 4 | - 33 |
| Business unit Czech Republic | - 7 | - 12 | - 1 | - 7 | - 2 |
| Business unit International Markets | 152 | 34 | 12 | 92 | 37 |
| of which: Hungary | 10 | 14 | 0 | 9 | 11 |
| of which: Slovakia | - 9 | - 8 | - 7 | - 1 | - 1 |
| of which: Bulgaria | - 11 | - 4 | - 7 | - 3 | - 1 |
| of which: Ireland | 162 | 32 | 26 | 87 | 28 |
| Group Centre | - 13 | - 27 | - 6 | - 11 | - 20 |
| Impairment on available-for-sale assets | - 9 | - 51 | - 6 | - 2 | - 7 |
| Breakdown by type | |||||
| Shares | - 9 | - 51 | - 6 | - 2 | - 7 |
| Other | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | - 16 | - 5 | - 11 | - 5 | - 3 |
| Intangible assets, other than goodwill | - 1 | - 1 | - 1 | 0 | 0 |
| Property and equipment and investment property | - 12 | - 2 | - 8 | - 4 | - 1 |
| Held-to-maturity assets | 0 | - 1 | 0 | 0 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | - 3 | - 1 | - 2 | - 1 | - 1 |
In 1Q 2017, the income tax expenses were positively influenced by 66 million euros of deferred tax assets (DTA) related to the liquidation of IIB Finance Ireland at KBC Bank NV. According to Belgian tax law, the loss in paid-in capital that KBC Bank sustained as a result of the liquidation of IIB Finance Ireland is tax deductible for the parent company on the date of liquidation, rather than at the time the losses were incurred.
The impact of the acquisition of UBB/Interlease on the financial assets and liabilities by product is shown in an additional pro forma column 'Total excluding UBB/Interlease' for informational purposes in order to provide a transparent view on the evolution of the financial assets and liabilities excluding this acquisition. For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| Held for | Designated at | Available for | Loans and | Hedging | Total excluding | |||
|---|---|---|---|---|---|---|---|---|
| In millions of EUR | trading | fair value | sale | receivables Held to maturity | derivatives | Total | UBB/Interlease | |
| FINANCIAL ASSETS, 30-09-2017 | ||||||||
| Loans and advances to credit institutions and | ||||||||
| investment firms a | 452 | 1 | 0 | 19 823 | - | - | 20 275 | 20 220 |
| Loans and advances to customers b | 21 | 40 | 0 | 140 404 | - | - | 140 466 | 138 645 |
| Excluding reverse repos | 1 | 40 | 0 | 139 497 | - | - | 139 538 | 137 726 |
| Trade receivables | 0 | 0 | 0 | 3 661 | - | - | 3 661 | 3 661 |
| Consumer credit | 0 | 0 | 0 | 3 883 | - | - | 3 883 | 3 545 |
| Mortgage loans | 0 | 26 | 0 | 59 292 | - | - | 59 318 | 58 904 |
| Term loans | 20 | 15 | 0 | 62 522 | - | - | 62 557 | 61 833 |
| Finance leasing | 0 | 0 | 0 | 5 308 | - | - | 5 308 | 5 157 |
| Current account advances | 0 | 0 | 0 | 5 120 | - | - | 5 120 | 4 926 |
| Securitised loans | 0 | 0 | 0 | 0 | - | - | 0 | 0 |
| Other | 1 | 0 | 0 | 619 | - | - | 620 | 620 |
| Equity instruments | 469 | 3 | 1 685 | - | - | - | 2 156 | 2 145 |
| Investment contracts (insurance) | - | 14 093 | - | - | - | - | 14 093 | 14 093 |
| Debt securities issued by | 1 361 | 229 | 33 736 | 956 | 30 834 | - | 67 117 | 66 440 |
| Public bodies | 1 122 | 40 | 22 528 | 59 | 28 888 | - | 52 637 | 52 016 |
| Credit institutions and investment firms | 174 | 174 | 5 159 | 127 | 1 241 | - | 6 875 | 6 830 |
| Corporates | 65 | 15 | 6 049 | 771 | 705 | - | 7 605 | 7 594 |
| Derivatives | 6 087 | - | - | - | - | 365 | 6 452 | 6 451 |
| Other | 0 | 0 | 0 | 518 | 0 | 0 | 518 | 518 |
| Total carrying value | 8 390 | 14 367 | 35 421 | 161 702 | 30 834 | 365 | 251 078 | 248 513 |
| a Of which reverse repos |
15 082 | 15 082 | ||||||
| b Of which reverse repos | 928 | 920 |
| Loans and advances to credit institutions and | |||||||
|---|---|---|---|---|---|---|---|
| investment firms a | 6 | 1 | 0 | 16 922 | - | - | 16 929 |
| Loans and advances to customers b | 1 | 77 | 0 | 133 154 | - | - | 133 231 |
| Excluding reverse repos | 1 | 45 | 0 | 132 810 | - | - | 132 856 |
| Trade receivables | 0 | 0 | 0 | 3 549 | - | - | 3 549 |
| Consumer credit | 0 | 0 | 0 | 3 180 | - | - | 3 180 |
| Mortgage loans | 0 | 29 | 0 | 57 307 | - | - | 57 335 |
| Term loans | 0 | 49 | 0 | 59 035 | - | - | 59 083 |
| Finance leasing | 0 | 0 | 0 | 4 916 | - | - | 4 916 |
| Current account advances | 0 | 0 | 0 | 4 640 | - | - | 4 640 |
| Other | 1 | 0 | 0 | 527 | - | - | 528 |
| Equity instruments | 427 | 2 | 1 723 | - | - | - | 2 153 |
| Investment contracts (insurance) | - | 13 693 | - | - | - | - | 13 693 |
| Debt securities issued by | 1 001 | 411 | 34 985 | 1 015 | 33 697 | - | 71 109 |
| Public bodies | 713 | 47 | 22 982 | 16 | 32 131 | - | 55 889 |
| Credit institutions and investment firms | 127 | 174 | 5 032 | 140 | 948 | - | 6 421 |
| Corporates | 161 | 190 | 6 970 | 859 | 618 | - | 8 799 |
| Derivatives | 8 249 | - | - | - | - | 410 | 8 659 |
| Other | 0 | 0 | 0 | 524 | - | - | 525 |
| Total carrying value | 9 683 | 14 184 | 36 708 | 151 615 | 33 697 | 410 | 246 298 |
| a Of which reverse repos | 11 776 | ||||||
| b Of which reverse repos | 376 |
| Held for | Designated at | Hedging | Measured at | Total excluding | ||
|---|---|---|---|---|---|---|
| In millions of EUR | trading | fair value | derivatives | amortised cost | Total | UBB/Interlease |
| FINANCIAL LIABILITIES, 30-09-2017 | ||||||
| Deposits from credit institutions and investment | ||||||
| firms a | 36 | 50 | - | 40 890 | 40 975 | 40 960 |
| Deposits from customers and debt certificates b | 346 | 1 714 | - | 188 765 | 190 824 | 187 691 |
| Excluding repos | 345 | 1 714 | - | 186 903 | 188 962 | 185 828 |
| Demand deposits | 0 | 0 | - | 71 739 | 71 739 | 70 200 |
| Time deposits | 90 | 717 | - | 20 556 | 21 362 | 20 510 |
| Saving accounts | 0 | 0 | - | 56 272 | 56 272 | 55 568 |
| Special deposits | 0 | 0 | - | 2 275 | 2 275 | 2 275 |
| Other deposits | 0 | 0 | - | 567 | 567 | 528 |
| Certificates of deposit | 0 | 9 | - | 18 916 | 18 925 | 18 925 |
| Customer savings certificates | 0 | 0 | - | 1 779 | 1 779 | 1 779 |
| Non-convertible bonds | 256 | 798 | - | 13 312 | 14 365 | 14 365 |
| Non-convertible subordinated liabilities | 0 | 190 | - | 3 349 | 3 540 | 3 540 |
| Liabilities under investment contracts | - | 13 294 | - | 0 | 13 294 | 13 294 |
| Derivatives | 5 804 | 0 | 1 490 | - | 7 294 | 7 294 |
| Short positions | 753 | 0 | - | - | 753 | 753 |
| in equity instruments | 46 | 0 | - | - | 46 | 46 |
| in debt instruments | 707 | 0 | - | - | 707 | 707 |
| Other | 6 | 0 | - | 2 472 | 2 478 | 2 478 |
| Total carrying value | 6 944 | 15 058 | 1 490 | 232 127 | 255 619 | 252 470 |
| a Of which repos | 12 180 | 12 180 | ||||
| b Of which repos | 1 863 | 1 863 |
Deposits from credit institutions and investment
| firms a | 5 | 1 766 | - | 30 248 | 32 020 |
|---|---|---|---|---|---|
| Deposits from customers and debt certificates b | 541 | 2 134 | - | 175 055 | 177 730 |
| Excluding repos | 536 | 1 869 | - | 175 017 | 177 421 |
| Demand deposits | 0 | 0 | - | 63 427 | 63 427 |
| Time deposits | 117 | 1 100 | - | 21 027 | 22 245 |
| Saving accounts | 0 | 0 | - | 53 328 | 53 328 |
| Special deposits | 0 | 0 | - | 2 056 | 2 056 |
| Other deposits | 0 | 0 | - | 630 | 630 |
| Certificates of deposit | 0 | 14 | - | 16 629 | 16 643 |
| Customer savings certificates | 0 | 0 | - | 1 959 | 1 959 |
| Non-convertible bonds | 424 | 744 | - | 12 889 | 14 057 |
| Non-convertible subordinated liabilities | 0 | 276 | - | 3 109 | 3 385 |
| Liabilities under investment contracts | - | 12 653 | - | 0 | 12 653 |
| Derivatives | 7 334 | - | 1 704 | - | 9 037 |
| Short positions | 665 | 0 | - | - | 665 |
| in equity instruments | 36 | 0 | - | - | 36 |
| in debt instruments | 629 | 0 | - | - | 629 |
| Other | 13 | 0 | - | 2 182 | 2 195 |
| Total carrying value | 8 559 | 16 553 | 1 704 | 207 485 | 234 300 |
| a Of which repos | 9 420 | ||||
| b Of which repos | 309 |
| In millions of EUR | 30-09-2017 | 30-06-2017 | 31-03-2017 | 31-12-2016 | 30-09-2016 |
|---|---|---|---|---|---|
| Total customer loans excluding reverse repo | |||||
| Business unit Belgium | 93 512 | 93 494 | 92 307 | 91 804 | 90 605 |
| Business unit Czech Republic | 22 155 | 21 520 | 20 253 | 19 552 | 19 269 |
| Business unit International Markets | 23 871 | 23 508 | 21 487 | 21 496 | 21 268 |
| of which: Hungary | 4 073 | 3 893 | 3 825 | 3 802 | 3 727 |
| of which: Slovakia | 6 434 | 6 284 | 6 217 | 6 094 | 5 910 |
| of which: Bulgaria | 2 695 | 2 684 | 826 | 835 | 773 |
| of which: Ireland | 10 669 | 10 648 | 10 618 | 10 765 | 10 859 |
| Group Centre | 0 | 0 | 0 | 4 | 268 |
| KBC Group | 139 538 | 138 522 | 134 047 | 132 856 | 131 410 |
| Mortgage loans | |||||
| Business unit Belgium | 34 222 | 34 079 | 34 085 | 34 265 | 34 079 |
| Business unit Czech Republic | 10 245 | 9 867 | 9 273 | 9 077 | 8 799 |
| Business unit International Markets | 14 850 | 14 661 | 14 058 | 13 993 | 13 897 |
| of which: Hungary | 1 532 | 1 494 | 1 469 | 1 451 | 1 441 |
| of which: Slovakia | 2 861 | 2 770 | 2 695 | 2 608 | 2 491 |
| of which: Bulgaria | 660 | 657 | 236 | 234 | 235 |
| of which: Ireland | 9 797 | 9 740 | 9 657 | 9 700 | 9 731 |
| Group Centre | 0 | 0 | 0 | 0 | 0 |
| KBC Group | 59 318 | 58 607 | 57 416 | 57 335 | 56 776 |
| Customer deposits and debt certificates excl. repos | |||||
| Business unit Belgium | 128 895 | 129 825 | 127 005 | 125 074 | 116 489 |
| Business unit Czech Republic | 29 529 | 28 925 | 27 770 | 26 183 | 25 403 |
| Business unit International Markets | 22 056 | 21 714 | 18 539 | 18 344 | 18 018 |
| of which: Hungary | 6 980 | 6 663 | 6 756 | 6 814 | 6 096 |
| of which: Slovakia | 5 714 | 5 820 | 5 745 | 5 739 | 5 840 |
| of which: Bulgaria | 3 998 | 3 846 | 808 | 792 | 750 |
| of which: Ireland | 5 364 | 5 385 | 5 229 | 4 999 | 5 333 |
| Group Centre | 8 481 | 8 244 | 7 793 | 7 820 | 7 624 |
| KBC Group | 188 962 | 188 708 | 181 107 | 177 421 | 167 534 |
Note: figures of which UBB/Interlease on 30 June 2017 (first consolidation of the balance sheet):
• total customer loans excluding reverse repo: 1 822 million euros
• mortgage loans: 419 million euros
• customer deposits and debt certificates excl. repos: 3 016 million euros
| 30-09-2017 | 30-06-2017 | 31-03-2017 | 31-12-2016 | 30-09-2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Interest | Interest | Interest | Interest | Unit | Interest | Unit | ||||
| In millions of EUR | Guaranteed Unit Linked | Guaranteed Unit Linked | Guaranteed Unit Linked | Guaranteed | Linked | Guaranteed | Linked | |||
| Business unit Belgium | 13 775 | 13 115 | 13 940 | 13 161 | 14 235 | 12 952 | 14 567 | 12 760 | 14 660 | 12 609 |
| Business unit Czech Republic | 601 | 556 | 594 | 549 | 576 | 525 | 575 | 525 | 575 | 460 |
| Business unit International Markets | 212 | 422 | 215 | 419 | 220 | 411 | 220 | 408 | 217 | 402 |
| of which: Hungary | 55 | 291 | 55 | 290 | 55 | 285 | 55 | 284 | 55 | 280 |
| of which: Slovakia | 113 | 126 | 113 | 125 | 113 | 123 | 116 | 122 | 112 | 120 |
| of which: Bulgaria | 44 | 5 | 47 | 4 | 52 | 3 | 49 | 2 | 50 | 2 |
| KBC Group | 14 588 | 14 093 | 14 749 | 14 129 | 15 031 | 13 887 | 15 362 | 13 693 | 15 452 | 13 471 |
Note: adjusted figures for reference periods.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2016.
| Fair value hierarchy | 30-09-2017 | 31-12-2016 | ||||||
|---|---|---|---|---|---|---|---|---|
| In millions of EUR | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Financial assets measured at fair value | ||||||||
| Held for trading | 1 217 | 5 075 | 2 097 | 8 390 | 1 034 | 6 585 | 2 064 | 9 683 |
| Designated at fair value | 13 684 | 509 | 174 | 14 367 | 13 377 | 616 | 191 | 14 184 |
| Available for sale | 28 896 | 5 607 | 918 | 35 421 | 31 427 | 3 716 | 1 565 | 36 708 |
| Hedging derivatives | 0 | 365 | 0 | 365 | 0 | 410 | 0 | 410 |
| Total | 43 797 | 11 556 | 3 189 | 58 542 | 45 838 | 11 328 | 3 820 | 60 986 |
| Financial liabilities measured at fair value | ||||||||
| Held for trading | 743 | 3 936 | 2 266 | 6 944 | 665 | 5 659 | 2 234 | 8 559 |
| Designated at fair value | 13 288 | 1 455 | 314 | 15 058 | 12 652 | 3 344 | 557 | 16 553 |
| Hedging derivatives | 0 | 1 490 | 0 | 1 490 | 0 | 1 704 | 0 | 1 704 |
| Total | 14 031 | 6 882 | 2 580 | 23 492 | 13 318 | 10 707 | 2 791 | 26 815 |
In the first 9 months of 2017, a total amount of 1 822 million euros in financial instruments at fair value was transferred from level 1 to level 2. KBC also transferred 197 million euros in financial instruments at fair value from level 2 to level 1. The majority of the transfers is due to a change in methodology driven by the implementation in 3Q 2017 of a fully automated process using the BVAL valuation for bonds of KBC Bank, CBC Banque, KBC Insurance and KBC Credit Investments. BVAL is a widely used pricing solution offered by Bloomberg which uses an average of market prices to provide quotes for bonds. The use of BVAL changes the decision tree for fair value levelling.
In the first 9 months of 2017 the following material movements are observed with respect to instruments classified in level 3 of the fair value level hierarchy:
| in number of shares | 30-09-2017 | 31-12-2016 |
|---|---|---|
| Ordinary shares | 418 372 082 | 418 372 082 |
| of which ordinary shares that entitle the holder to a dividend payment | 418 372 082 | 418 372 082 |
| of which treasury shares | 65 946 | 2 |
| Other information | ||
| Par value per ordinary share (in EUR) | 3,48 | 3,48 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels). The treasury shares at 30 September 2017 almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
In 2016: no material changes
On 30 December 2016, KBC announced the acquisition of 99,91% of the shares of the United Bulgarian Bank AD and 100% of Interlease EAD in Bulgaria for a total consideration of 610 million euros, without any contingent consideration. On 13 June 2017, KBC completed this acquisition after approval by the relevant regulatory authorities and received anti-trust approval (final total consideration is 609 million euros fully paid in cash).
This transaction substantially strengthens KBC's position in Bulgaria. UBB is Bulgaria's fourth-largest banking group by total assets with market share of 7,4% as at the end of March 2017. UBB caters for approximately 875 000 retail clients with market share of 9,7% in retail loans. UBB also has a strong presence in the corporate banking market with a share of 7,6% in corporate loans. The table below summarizes the provisional fair values of the main assets and liabilities which are part of the acquisition of UBB/Interlease.
Together, UBB-CIBANK and DZI will become the reference in bank-insurance in Bulgaria, one of KBC's core markets. Following this acquisition, KBC will also become active in leasing, asset management and factoring in Bulgaria, offering its clients now a full range of financial services.
The operational integration of the business entities will be gradually introduced in the coming months. KBC envisages substantial value creation for shareholders through income and cost synergies.
The consolidated figures in these condensed interim financial statements include the impact of this announced acquisition as of 30 June 2017:
| in millions of EUR | End of June 2017 |
|---|---|
| Percentage of shares bought (+) or sold (-) in the relevant year | UBB 99,91% / Interlease 100% |
| For business unit/segment | Bulgaria |
| Deal date (month and year) | June 2017 |
| Incorporation of the result of the company in the result of the group as of: | 01-07-2017 |
| Purchase price or sale price | 609 |
| Cashflow for acquiring or selling companies less cash and cash equivalents acquired | 185 |
| Recognised amounts of identifiable assets acquired and liabilities assumed - provisional fair value (*) | |
| Cash and cash balances with central banks | 693 |
| Financial assets | 2 810 |
| Held for trading | 502 |
| Available for sale | 335 |
| Loans and receivables | 1 973 |
| Tax assets | 12 |
| Investments in associated companies and joint ventures | 17 |
| Investment property | 15 |
| Property and equipment | 20 |
| Goodwill and other intangible assets | 4 |
| Other assets | 20 |
| of which: cash and cash equivalents | 801 |
| Financial liabilities | 3 063 |
| Measured at amortised cost | 3 062 |
| Other liabilities | 20 |
| of which: cash and cash equivalents | 7 |
| (*) after elimination of intragroup transactions within the KBC Group | |
| in millions of EUR | |
| Contribution to the consolidated income statement of 3Q 2017 of UBB/Interlease | 3Q 2017 |
| Net interest income | 28 |
| Dividend income | 0 |
| Net result from financial instruments at fair value through profit or loss | 6 |
| Net realised result from available-for-sale assets | 0 |
| Net fee and commission income | 12 |
| Net other income | -4 |
| TOTAL INCOME | 42 |
| Operating expenses | -20 |
| Impairment | -7 |
| on loans and receivables | -6 |
| on available-for-sale assets | -1 |
| on goodwill on other |
0 0 |
| Share in results of associated companies and joint ventures | 0 |
| RESULT BEFORE TAX | 16 |
| Income tax expense RESULT AFTER TAX |
-2 14 |
| Attributable to minority interests | 0 |
| NET RESULT | 14 |
Significant non-adjusting events between the balance sheet date (30 September 2017) and the publication of this report (16 November 2017):
The planned reform of the Belgian corporate income tax regime, as announced on 26 July 2017, will impact KBC mainly because of the gradual decrease of the tax rate from 33,99% to 29,58% as of accounting year 2018 and to 25% as of accounting year 2020. Based on the expectation that the new ratios will be substantially enacted by the end of 2017. This would lead to:
o a slightly positive one-off impact on the CET1 ratio (fully loaded under the Danish Compromise) in 4Q 2017 of roughly +0.2% thanks to amongst others:
We have reviewed the accompanying interim consolidated balance sheet of KBC Group NV and its subsidiaries (collectively referred to as "the Group") as at 30 September 2017 and the related interim consolidated income statement and condensed consolidated statement of-comprehensive income for the nine-month period then ended, and the interim consolidated statement of changes in equity and condensed consolidated cash flow statement for the nine-month period then ended, and explanatory notes, comprising a summary of significant accounting policies and other explanatory notes, collectively, the "Interim Condensed Consolidated Financial Statements".
These statements show a consolidated balance sheet total of EUR 296.885 million and a consolidated profit (share of the group) for the nine-month period then ended of EUR 2.176 million.
The board of directors is responsible for the preparation and fair presentation of these Interim Condensed Consolidated Financial Statements in accordance with International Financial Reporting Standard IAS 34 Interim Financial Reporting ("IAS 34") as adopted for use in the European Union. Our responsibility is to express a conclusion on these Interim Condensed Consolidated Financial Statements based on our review.
We conducted our review in accordance with the International Standard on Review Engagements 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" applicable to review engagements. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the International Standards on Auditing and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
29
r,·············································· .. ·····················••••u••···················••u, .. , .............................................................................................................................. .. PwG Bedriifsrevisoren cvba, burgerlijke vennootschap met handelsvorm - PwG Reviseurs d'Entreprises scrl, societe civile aforme commerciale - Financial Assurance Services Maatschappelijke zetel/Siege social: Woluwe Garden, Woluwedal 18, B-1932 Sint-Stevens-Woluwe T: +32 (0)2 710 4211, F: +32 (0)2 710 4299, www.pwc.com BTW/TVA BE 0429,501.944 / RPR Brussel - RPM Bruxelles/ ING BE43 3101 3811 9501 - BIG BBRUBEBB / BELFIUS BE92 0689 0408 8123 - BIG GKCC BEBB
Based on our review, nothing has come to our attention that causes us to believe that the accompanying Interim Condensed Consolidated Financial Statements do not present fairly, in all material respects, the financial position of the Group as at 30 September 2017, and of its financial performance and its cash flows for the nine-month period then ended in accordance with IAS 34, as adopted for use in the European Union.
Sint-Stevens-Woluwe, 15 November 2017
statutory auditor edrijfsrevisoren bcvba e nted by
Tom Meuleman
Accredited auditor
Section not reviewed by the Auditor
The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit (except for confirmations of letters of credit and similar export-/import-related commercial credit), standby credit and credit derivatives, granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'note 6.7 (in the annual accounts 2016)'.
| Total loan portfolio (in billions of EUR) | 30-09-2017 | 31-12-2016 |
|---|---|---|
| Amount granted | 188 | 181 |
| Amount outstanding 1 | 153 | 148 |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 63% | 65% |
| Czech Republic | 16% | 15% |
| International Markets | 18% | 17% |
| Group Centre | 3% | 3% |
| Total | 100% | 100% |
| Total outstanding loan portfolio sector breakdown | ||
| Private persons | 42.1% | 42.3% |
| Finance and insurance Authorities |
5.7% | 5.7% |
| Corporates | 2.8% | 3.1% |
| services | 49.5% | 48.9% |
| distribution | 11.4% | 11.5% |
| real estate | 7.6% 6.9% |
7.6% 6.9% |
| building & construction | 4.2% | 4.2% |
| agriculture, farming, fishing | 2.8% | 2.8% |
| automotive | 2.3% | 2.2% |
| electricity food producers |
1.6% | 1.6% |
| metals | 1.5% | 1.4% |
| shipping | 1.4% | 1.4% |
| chemicals | 1.2% | 1.2% |
| machinery & heavy equipment | 1.2% 1.1% |
1.1% 1.1% |
| traders | 0.9% | 0.9% |
| hotels, bars & restaurants | 0.8% | 0.9% |
| oil, gas & other fuels | 0.8% | 0.7% |
| electrotechnics | 0.6% | 0.6% |
| textile & apparel other 2 |
0.5% | 0.4% |
| 2.7% | 2.5% | |
| Total outstanding loan portfolio geographical breakdown | ||
| Home countries | 88.4% | 88.2% |
| Belgium | 54.9% | 56.8% |
| Czech Republic | 15.1% | 14.0% |
| Ireland | 8.2% | 8.9% |
| Slovakia Hungary |
4.9% 3.2% |
4.8% 3.1% |
| Bulgaria | 2.2% | 0.6% |
| Rest of Western Europe | 7.4% | 7.3% |
| France | 1.8% | 1.8% |
| Netherlands | 1.7% | 1.7% |
| Great Britain | 1.1% | 1.1% |
| Spain | 0.5% | 0.6% |
| Luxemburg | 0.5% | 0.6% |
| Germany | 0.6% 1.1% |
0.4% 1.0% |
| other Rest of Central Europe |
0.4% | 0.5% |
| Russia | 0.1% | 0.1% |
| other | 0.4% | 0.4% |
| North America | 1.4% | 1.6% |
| USA | 1.1% | 1.4% |
| Canada | 0.3% | 0.2% |
| Asia | 0.8% | 0.8% |
| China | 0.3% | 0.3% |
| Hong Kong Singapore |
0.2% 0.2% |
0.2% 0.2% |
| other | 0.1% | 0.1% |
| Rest of the world | 1.5% | 1.6% |
| 30-09-2017 | 31-12-2016 | |
|---|---|---|
| Impaired loans (in millions of EUR or %) | ||
| Amount outstanding | 10 060 | 10 583 |
| of which: more than 90 days past due | 5 702 | 5 711 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 2.8% | 3.3% |
| Czech Republic | 2.5% | 2.8% |
| International Markets | 22.4% | 25.4% |
| Group Centre | 9.7% | 8.8% |
| Total | 6.6% | 7.2% |
| of which: more than 90 days past due | 3.7% | 3.9% |
| Specific loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Specific loan loss impairments | 4 777 | 4 874 |
| of which: more than 90 days past due | 3 676 | 3 603 |
| Cover ratio of impaired loans | ||
| Specific loan loss impairments / impaired loans | 47% | 46% |
| of which: more than 90 days past due | 64% | 63% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Specific loan loss impairments / impaired loans, mortgage loans excluded | 57% | 54% |
| of which: more than 90 days past due | 74% | 72% |
| Credit cost, by business unit (%) | ||
| Belgium | 0.10% | 0.12% |
| Czech Republic | 0.04% | 0.11% |
| International Markets | -0.74% | -0.16% |
| Slovakia | 0.17% | 0.24% |
| Hungary | -0.27% | -0.33% |
| Bulgaria | 0.85% | 0.32% |
| Ireland | -1.68% | -0.33% |
| Group Centre | 0.40% | 0.67% |
| Total | -0.05% | 0.09% |
1 Outstanding amount includes all on-balance sheet commitments and off-balance sheet guarantees 2 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2016 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the (new) definition used by EBA.
The loan portfolios of United Bulgarian Bank AD and Interlease EAD are included in the 30 September 2017 figures for a total outstanding amount of 2.4 billion euros. This amount differs from the accounting figure of loans and advances to customers excluding reverse repos mainly since the latter amount is net of impairment. The loan portfolios are assigned to Business Unit International Markets, country Bulgaria and included in all the reported ratio's .
| Loan portfolio Business Unit Belgium | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 30-09-2017, in millions of EUR | Belgium 1 | Foreign branches | Total Business Unit Belgium | ||||||
| Total outstanding amount | 90 234 | 6 099 | 96 333 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| SME / corporate | 26 473 | 29,3% | 6 099 | 100,0% | 32 572 | 33,8% | |||
| retail | 63 761 | 70,7% | 0 | 0,0% | 63 761 | 66,2% | |||
| o/w private | 34 999 | 38,8% | 0 | 0,0% | 34 999 | 36,3% | |||
| o/w companies | 28 761 | 31,9% | 0 | 0,0% | 28 761 | 29,9% | |||
| Mortgage loans 2 | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||
| total | 33 514 | 37,1% | 61% | 0 | 0,0% | - | 33 514 | 34,8% | |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - | 0 | 0,0% | |
| o/w ind. LTV > 100% | 1 403 | 1,6% | - | 0 | 0,0% | - | 1 403 | 1,5% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 68 606 | 76,0% | 3 697 | 60,6% | 72 303 | 75,1% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 16 735 | 18,5% | 1 934 | 31,7% | 18 669 | 19,4% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 2 433 | 2,7% | 122 | 2,0% | 2 555 | 2,7% | |||
| impaired loans (PD 10 - 12) | 2 401 | 2,7% | 344 | 5,6% | 2 745 | 2,8% | |||
| unrated | 59 | 0,1% | 2 | 0,0% | 60 | 0,1% | |||
| Overall risk indicators | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | |||
| outstanding impaired loans | 2 401 | 1 150 | 47,9% | 344 | 179 | 52,0% | 2 745 | 1 329 | 48,4% |
| o/w PD 10 impaired loans | 1 036 | 208 | 20,1% | 235 | 93 | 39,7% | 1 271 | 302 | 23,7% |
| o/w more than 90 days past due (PD 11+12) | 1 365 | 942 | 69,0% | 109 | 85 | 78,3% | 1 474 | 1 027 | 69,7% |
| all impairments (specific + portfolio based) | n.a. | n.a. | 1 428 | ||||||
| o/w portfolio based impairments | n.a. | n.a. | 100 | ||||||
| o/w specific impairments | 1 150 | 179 | 1 329 | ||||||
| 2016 Credit cost ratio (CCR) | 0,11% | 0,32% | 0,12% | ||||||
| YTD 2017 CCR | 0,10% | 0,21% | 0,10% | ||||||
1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches), CBC, KBC Lease part Belgium, KBC Commercial Finance,
KBC Credit Investments (part of non-legacy portfolio assigned to BU Belgium)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
| 30-09-2017, in millions of EUR | For information: ČMSS 3 (consolidated via equity-method) |
|||||
|---|---|---|---|---|---|---|
| Total outstanding amount | 24 590 | 2 495 | ||||
| Counterparty break down | % outst. | % outst. | ||||
| SME / corporate | 8 456 | 34,4% | 44 | 1,8% | ||
| retail | 16 134 | 65,6% | 2 450 | 98,2% | ||
| o/w private | 11 646 | 47,4% | 2 438 | 97,7% | ||
| o/w companies | 4 488 | 18,3% | 12 | 0,5% | ||
| Mortgage loans 1 | % outst. | ind. LTV | % outst. | ind. LTV | ||
| total | 10 559 | 42,9% | 66% | 1.906 | 76,4% | 64% |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - |
| o/w ind. LTV > 100% | 260 | 1,1% | - | 124 | 5,0% | - |
| Probability of default (PD) | % outst. | % outst. | ||||
| low risk (PD 1-4; 0.00%-0.80%) | 17 295 | 70,3% | 1 866 | 74,8% | ||
| medium risk (PD 5-7; 0.80%-6.40%) | 5 899 | 24,0% | 392 | 15,7% | ||
| high risk (PD 8-9; 6.40%-100.00%) | 755 | 3,1% | 157 | 6,3% | ||
| impaired loans (PD 10 - 12) | 611 | 2,5% | 80 | 3,2% | ||
| unrated | 31 | 0,1% | 0 | 0,0% | ||
| Overall risk indicators 2 | spec. imp. | % cover | spec. imp. | % cover | ||
| outstanding impaired loans | 611 | 334 | 54,7% | 80 | 40 | 50,4% |
| o/w PD 10 impaired loans | 208 | 56 | 26,9% | 11 | 2 | 14,9% |
| o/w more than 90 days past due (PD 11+12) | 403 | 278 | 69,0% | 69 | 38 | 56,1% |
| all impairments (specific + portfolio based) | 377 | 45 | ||||
| o/w portfolio based impairments | 43 | 5 | ||||
| o/w specific impairments | 334 | 40 | ||||
| 2016 Credit cost ratio (CCR) | 0,11% | n/a | ||||
| YTD 2017 CCR | 0,04% | 0,14% | ||||
1 Mortgage loans: only to private persons (as opposed to the accounting figures)
2 CCR at country level in local currency
3 ČMSS: pro-rata figures, corresponding with KBC's 55%-participation in ČMSS
| 30-09-2017, in millions of EUR | Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total outstanding amount | 12 598 | 7 183 | 4 803 | 3 395 | 27 995 | ||||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 1 375 | 10.9% | 2 825 | 39.3% | 2 790 | 58.1% | 964 | 28.4% | 7 970 | 28.5% | |||||
| retail | 11 223 | 89.1% | 4 359 | 60.7% | 2 013 | 41.9% | 2 431 | 71.6% | 20 025 | 71.5% | |||||
| o/w private | 11 213 | 89.0% | 3 512 | 48.9% | 1 843 | 38.4% | 1 328 | 39.1% | 17 897 | 63.9% | |||||
| o/w companies | 10 | 0.1% | 846 | 11.8% | 169 | 3.5% | 1 103 | 32.5% | 2 128 | 7.6% | |||||
| Mortgage loans 1 | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||||
| total | 11 176 | 88.7% | 76% | 3 044 | 42.4% | 69% | 1 681 | 35.0% | 68% | 673 | 19.8% | 73% | 16 575 | 59.2% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 10 | 0.2% | 126% | 135 | 4.0% | 70% | 145 | 0.5% | |
| o/w ind. LTV > 100% | 2 124 | 16.9% | - | 37 | 0.5% | - | 270 | 5.6% | - | 53 | 1.6% | - | 2 485 | 8.9% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 737 | 5.8% | 5 280 | 73.5% | 2 292 | 47.7% | 586 | 17.3% | 8 903 | 31.8% | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | 5 736 | 45.5% | 1 393 | 19.4% | 1 871 | 39.0% | 1 624 | 47.8% | 10 632 | 38.0% | |||||
| high risk (PD 8-9; 6.40%-100.00%) | 1 247 | 9.9% | 274 | 3.8% | 294 | 6.1% | 168 | 5.0% | 1 984 | 7.1% | |||||
| impaired loans (PD 10 - 12) | 4 879 | 38.7% | 203 | 2.8% | 343 | 7.2% | 848 | 25.0% | 6 273 | 22.4% | |||||
| unrated | 0 | 0.0% | 33 | 0.5% | 2 | 0.0% | 169 | 5.0% | 204 | 0.7% | |||||
| Overall risk indicators 2 | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | |||||
| outstanding impaired loans | 4 879 | 1 977 | 40.5% | 203 | 133 | 65.2% | 343 | 200 | 58.1% | 848 | 542 | 63.9% | 6 273 | 2 851 | 45.4% |
| o/w PD 10 impaired loans | 2 575 | 670 | 26.0% | 31 | 13 | 41.5% | 62 | 19 | 30.9% | 82 | 7 | 8.4% | 2 750 | 709 | 25.8% |
| o/w more than 90 days past due (PD 11+12) | 2 303 | 1 307 | 56.8% | 172 | 119 | 69.6% | 282 | 181 | 64.1% | 766 | 535 | 69.8% | 3 523 | 2 142 | 60.8% |
| all impairments (specific + portfolio based) | 2 045 | 146 | 211 | 550 | 2 952 | ||||||||||
| o/w portfolio based impairments | 68 | 14 | 11 | 8 | 101 | ||||||||||
| o/w specific impairments | 1 977 | 133 | 200 | 542 | 2 851 | ||||||||||
| 2016 Credit cost ratio (CCR) | -0.33% | 0.24% | -0.33% | 0.32% | -0.16% | ||||||||||
| YTD 2017 CCR | -1.68% | 0.17% | -0.27% | 0.85% | -0.74% |
Total Int Markets: total outstanding amount includes a small amount of KBC internal risk sharings which were eliminated at country level
1 Mortgage loans: only to private persons (as opposed to the accounting figures)
2 CCR at country level in local currency
| Total outstanding amount | 4 420 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 4 420 | 100.0% | |
| retail | 0 | 0.0% | |
| o/w private | 0 | 0.0% | |
| o/w companies | 0 | 0.0% | |
| Mortgage loans 2 | % outst. | ind. LTV | |
| total | 0 | 0.0% | - |
| o/w FX mortgages | 0 | 0.0% | - |
| o/w ind. LTV > 100% | 0 | 0.0% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 2 659 | 60.1% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 1 214 | 27.5% | |
| high risk (PD 8-9; 6.40%-100.00%) | 117 | 2.7% | |
| impaired loans (PD 10 - 12) | 430 | 9.7% | |
| unrated | 0 | 0.0% | |
| Overall risk indicators | spec. Imp. | % cover | |
| outstanding impaired loans | 430 | 263 | 61.1% |
| o/w PD 10 impaired loans | 128 | 35 | 27.1% |
| o/w more than 90 days past due (PD 11+12) | 303 | 228 | 75.4% |
| all impairments (specific + portfolio based) | 289 | ||
| o/w portfolio based impairments | 26 | ||
| o/w specific impairments | 263 | ||
| 2016 Credit cost ratio (CCR) | 0.67% | ||
| YTD 2017 CCR | 0.40% |
1 Total Group Centre = KBC Credit Investments (part of non-legacy portfolio assigned to BU Group),
ex-Atomium assets, KBC Bank part Group (a.o. activities in wind-down: e.g. ex-Antwerp Diamond Bank)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014, and will be fully implemented by 1 January 2022. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). KBC meets the FICOD requirement by aligning the building block method with method 1 (the accounting consolidation method) under FICOD. This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II (as of 2016) for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 81% of the weighted credit risks, of which approx. 75% according to Advanced and approx. 6% according to Foundation approach. Note that, retail exposure treated under IRB is always subject to an Advanced approach. The remaining weighted credit risks (ca. 19%) are calculated according to the Standardised approach. 12% of the latter, under the Danish Compromise, are the 370% risk-weighted holdings of own funds instruments of the insurance company.
The 2017 minimum CET1 requirement that KBC is to uphold is set at 8.65% (phased-in, Danish Compromise) which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (1.25% Capital Conservation Buffer, 1.00% Systemic Buffer and 0.15% Countercycle Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%. For further information see press release of 14 December 2016 on www.kbc.com.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| numerator | denominator | |||
|---|---|---|---|---|
| (common equity) | (total weighted risk volume) | ratio (%) | ||
| CRDIV, Common Equity ratio | ||||
| Phased-in | 14 662 | 91 098 | 16,10% | |
| Danish Compromise | Fully loaded | 14 596 | 91 535 | 15,95% |
| Deduction Method | Fully loaded | 13 587 | 86 050 | 15,79% |
| Financial Conglomerates Directive* | ||||
| Fully loaded | 15 725 | 103 749 | 15,16% |
| 30-09-2017 | 31-12-2016 | |||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased-in | Fully loaded | Phased-in |
| Total regulatory capital (after profit appropriation) | 18 253 | 18 312 | 17 571 | 17 887 |
| Tier-1 capital | 15 996 | 16 081 | 15 286 | 15 473 |
| Common equity | 14 596 | 14 662 | 13 886 | 14 033 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 16 352 | 16 352 | 15 500 | 15 500 |
| Intangible fixed assets (incl deferred tax impact) (-) | - 445 | - 445 | - 400 | - 400 |
| Goodwill on consolidation (incl deferred tax impact) (-) | - 600 | - 600 | - 483 | - 483 |
| AFS revaluation reserve bonds (-) | - 102 | - 206 | ||
| Hedging reserve (cash flow hedges) (-) | 1 167 | 1 167 | 1 356 | 1 356 |
| Valuation diff. in fin. liabilities at fair value - own credit risk (-) | - 3 | - 3 | - 18 | - 18 |
| Value adjustment due to the requirements for prudent valuation (-) | - 117 | - 105 | - 140 | - 109 |
| Dividend payout (-) | - 632 | - 632 | - 753 | - 753 |
| Renumeration of AT1 instruments (-) | - 2 | - 2 | - 2 | - 2 |
| Deduction re. financing provided to shareholders (-) | - 92 | - 92 | - 91 | - 91 |
| IRB provision shortfall (-) | - 224 | - 224 | - 203 | - 203 |
| Deferred tax assets on losses carried forward (-) | - 809 | - 653 | - 879 | - 557 |
| Additional going concern capital | 1 400 | 1 419 | 1 400 | 1 440 |
| Grandfathered innovative hybrid tier-1 instruments | 0 | 19 | 0 | 40 |
| CRR compliant AT1 instruments | 1 400 | 1 400 | 1 400 | 1 400 |
| Tier 2 capital | 2 257 | 2 231 | 2 285 | 2 414 |
| IRB provision excess (+) | 358 | 358 | 367 | 362 |
| Subordinated liabilities | 1 900 | 1 873 | 1 918 | 2 053 |
| Total weighted risk volume | 91 535 | 91 098 | 87 782 | 86 878 |
| Banking | 82 261 | 81 823 | 78 482 | 77 579 |
| Insurance | 9 133 | 9 133 | 9 133 | 9 133 |
| Holding activities | 182 | 182 | 198 | 198 |
| Elimination of intercompany transactions | - 41 | - 41 | - 32 | - 32 |
| Solvency ratios | ||||
| Common equity ratio | 15,95% | 16,10% | 15,82% | 16,15% |
| Tier-1 ratio | 17,48% | 17,65% | 17,41% | 17,81% |
| Total capital ratio (*) |
19,94% | 20,10% | 20,02% | 20,59% |
(*) We intend to call the USD contingent convertible note (coco) in January 2018. Hence, the capital value of the coco has already been excluded from Tier-2. The impact of the coco call is largely offset by the successful issuance of a Tier 2 benchmark issuance in September 2017.
| FICOD | 30-09-2017 | 31-12-2016 | ||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased-in | Fully loaded | Phased-in |
| Common Equity | 15 725 | 15 792 | 14 647 | 14 794 |
| Total weighted risk volume | 103 749 | 103 312 | 101 039 | 100 136 |
| Solvency ratio | ||||
| Common equity ratio | 15,16% | 15,29% | 14,50% | 14,77% |
| Tier-1 capital (Danish compromise) 15 996 15 286 Total exposures 277 675 251 891 Total Assets 296 885 275 200 Deconsolidation KBC Insurance -32 562 -32 678 Adjustment for derivatives -3 897 -5 784 Adjustment for regulatory corrections in determining Basel III Tier-1 capital -2 287 -2 197 Adjustment for securities financing transaction exposures 2 617 1 094 Off-balance sheet exposures 16 920 16 256 Leverage ratio 5,76% 6,07% |
In millions of EUR | 30-09-2017 | 31-12-2016 |
|---|---|---|---|
The leverage ratio decreased compared to the end of 2016 due to higher total exposures (mainly caused by an increase in reverse repos and cash balances with central banks), partly compensated by a higher Tier-1 capital (Danish compromise).
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR | 30-09-2017 | 31-12-2016 | ||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased in | Fully loaded | Phased in |
| Total regulatory capital, after profit appropriation | 15 251 | 15 304 | 16 229 | 16 347 |
| Tier-1 capital | 12 924 | 13 003 | 12 625 | 12 803 |
| Of which common equity | 11 518 | 11 573 | 11 219 | 11 348 |
| Tier-2 capital | 2 327 | 2 301 | 3 604 | 3 544 |
| Total weighted risks | 82 261 | 81 823 | 78 482 | 77 579 |
| Credit risk | 68 750 | 68 313 | 65 933 | 65 030 |
| Market risk | 3 084 | 3 084 | 2 417 | 2 417 |
| Operational risk | 10 427 | 10 427 | 10 132 | 10 132 |
| Solvency ratios | ||||
| Common equity ratio | 14,0% | 14,1% | 14,3% | 14,6% |
| Tier-1 ratio | 15,7% | 15,9% | 16,1% | 16,5% |
| (*) CAD ratio |
18,5% | 18,7% | 20,7% | 21,1% |
(*) We intend to call the USD contingent convertible note (coco) in January 2018. Hence, the capital value of the coco has already been excluded from Tier-2.
| In millions of EUR | 30-09-2017 | 31-12-2016 |
|---|---|---|
| Own Funds | 3 766 | 3 637 |
| Tier 1 | 3 266 | 3 137 |
| IFRS Parent shareholders equity | 3 130 | 2 936 |
| Dividend payout | - 343 | - 103 |
| Deduction intangible assets and goodwill (after tax) | - 125 | - 123 |
| Valuation differences (after tax) | 513 | 349 |
| Volatility adjustment | 97 | 120 |
| Other | - 6 | - 42 |
| Tier 2 | 500 | 500 |
| Subordinated liabilities | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 708 | 1 791 |
| Market risk | 1 594 | 1 589 |
| Non-life | 528 | 531 |
| Life | 613 | 608 |
| Health | 196 | 181 |
| Counterparty | 107 | 87 |
| Diversification | - 904 | - 881 |
| Other | - 427 | - 323 |
| Solvency II ratio | 221% | 203% |
In April 2016, the National Bank of Belgium issued a Belgian specific regulation which limited the loss absorbing capacity of deferred taxes in the calculation of the required capital. Without applying this Belgian specific regulation, the Solvency II ratio of year-end 2016 equals 214%.
On 19 April 2017, the NBB retroactively waived the strict cap on the loss absorbing capacity of deferred taxes in the calculation of the required capital. Belgian insurance companies are now allowed to apply a higher adjustment for deferred taxes, in line with general European standards, if they pass the recoverability test. This is the case for KBC.
Details on our segments or business units are available in the company presentation.
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 589 | 611 | 625 | 651 | 680 |
| Non-life insurance before reinsurance | 153 | 131 | 143 | 122 | 118 |
| Earned premiums Non-life | 263 | 258 | 256 | 257 | 256 |
| Technical charges Non-life | - 111 | - 127 | - 113 | - 135 | - 138 |
| Life insurance before reinsurance | - 21 | - 43 | - 44 | - 62 | - 47 |
| Earned premiums Life | 195 | 199 | 241 | 298 | 257 |
| Technical charges Life | - 216 | - 242 | - 285 | - 360 | - 304 |
| Ceded reinsurance result | 4 | - 7 | - 2 | - 8 | 11 |
| Dividend income | 9 | 24 | 12 | 15 | 10 |
| Net Result from FIFV through profit or loss | 106 | 127 | 156 | 174 | 69 |
| Net Realised result from Available for sale assets | 34 | 32 | 23 | 6 | 12 |
| Net Fee and Commission Income | 301 | 331 | 346 | 279 | 272 |
| Net other income | 51 | 40 | 46 | 66 | 53 |
| Total income | 1 225 | 1 245 | 1 305 | 1 244 | 1 177 |
| Operating expenses | - 520 | - 544 | - 822 | - 556 | - 529 |
| Impairment | - 34 | 2 | - 60 | - 60 | - 41 |
| Impairment on Loans and receivables | - 21 | 4 | - 59 | - 46 | - 33 |
| Impairment on available-for-sale assets | - 5 | - 2 | - 1 | - 7 | - 7 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | - 8 | - 1 | 0 | - 7 | - 1 |
| Share in results of assoc. comp & joint-ventures | 0 | - 4 | 0 | 0 | 1 |
| Result before tax | 672 | 698 | 423 | 628 | 608 |
| Income tax | - 217 | - 215 | - 121 | - 189 | - 193 |
| Result after tax | 455 | 484 | 301 | 439 | 414 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 455 | 483 | 301 | 439 | 414 |
| Banking | 336 | 385 | 208 | 371 | 330 |
| Insurance | 119 | 98 | 93 | 68 | 84 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 43 988 | 43 329 | 42 797 | 42 566 | 42 537 |
| Required capital, insurance (Solv.II as of '16) | 1 503 | 1 444 | 1 494 | 1 611 | 1 782 |
| Allocated capital (end of period) | 6 078 | 5 950 | 5 945 | 5 974 | 6 142 |
| Return on allocated capital (ROAC) | 30% | 32% | 20% | 29% | 28% |
| Cost/income ratio, banking | 46% | 45% | 67% | 45% | 47% |
| Combined ratio, non-life insurance | 78% | 86% | 77% | 92% | 86% |
| Net interest margin, banking | 1,51% | 1,61% | 1,67% | 1,72% | 1,78% |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 218 | 220 | 216 | 215 | 213 |
| Non-life insurance before reinsurance | 25 | 22 | 18 | 24 | 17 |
| Earned premiums Non-life | 56 | 53 | 49 | 50 | 49 |
| Technical charges Non-life | - 31 | - 31 | - 30 | - 27 | - 32 |
| Life insurance before reinsurance | 12 | 12 | 11 | 10 | 10 |
| Earned premiums Life | 68 | 47 | 48 | 94 | 59 |
| Technical charges Life | - 56 | - 35 | - 38 | - 84 | - 49 |
| Ceded reinsurance result | - 2 | - 2 | - 1 | - 3 | 2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 53 | 65 | 50 | 24 | 20 |
| Net Realised result from Available for sale assets | - 1 | 6 | 11 | 0 | 0 |
| Net Fee and Commission Income | 43 | 47 | 47 | 50 | 46 |
| Net other income | 5 | 5 | 26 | 2 | 7 |
| Total income | 354 | 375 | 378 | 322 | 314 |
| Operating expenses | - 153 | - 151 | - 165 | - 152 | - 144 |
| Impairment | - 3 | - 11 | 1 | - 11 | - 2 |
| Impairment on Loans and receivables | - 1 | - 7 | 1 | - 11 | - 2 |
| Impairment on available-for-sale assets | 0 | 0 | 0 | 3 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | - 2 | - 3 | 0 | - 3 | 0 |
| Share in results of assoc. comp & joint-ventures | 6 | 6 | 4 | 4 | 8 |
| Result before tax | 205 | 219 | 218 | 163 | 175 |
| Income tax | - 34 | - 37 | - 37 | - 33 | - 30 |
| Result after tax | 170 | 183 | 181 | 131 | 145 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 170 | 183 | 181 | 131 | 145 |
| Banking | 162 | 176 | 174 | 118 | 137 |
| Insurance | 9 | 7 | 7 | 13 | 8 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 14 855 | 15 039 | 14 386 | 13 664 | 13 921 |
| Required capital, insurance (Solv.II as of '16) | 118 | 116 | 110 | 103 | 90 |
| Allocated capital (end of period) | 1 662 | 1 680 | 1 606 | 1 504 | 1 517 |
| Return on allocated capital (ROAC) | 42% | 47% | 48% | 36% | 41% |
| Cost/income ratio, banking | 42% | 39% | 43% | 47% | 45% |
| Combined ratio, non-life insurance | 95% | 97% | 100% | 93% | 96% |
| Net interest margin, banking | 2,85% | 3,01% | 3,06% | 2,96% | 2,91% |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 226 | 194 | 189 | 198 | 184 |
| Non-life insurance before reinsurance | 8 | 23 | 25 | 24 | 24 |
| Earned premiums Non-life | 56 | 57 | 53 | 52 | 50 |
| Technical charges Non-life | - 48 | - 34 | - 28 | - 28 | - 27 |
| Life insurance before reinsurance | 6 | 6 | 6 | 7 | 3 |
| Earned premiums Life | 18 | 21 | 23 | 21 | 20 |
| Technical charges Life | - 12 | - 15 | - 17 | - 14 | - 17 |
| Ceded reinsurance result | 13 | 0 | - 1 | - 2 | - 2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 25 | 19 | 28 | 24 | 11 |
| Net Realised result from Available for sale assets | 1 | 0 | 2 | 2 | 0 |
| Net Fee and Commission Income | 65 | 54 | 48 | 50 | 52 |
| Net other income | - 57 | 1 | 4 | 2 | - 2 |
| Total income | 287 | 297 | 301 | 305 | 271 |
| Operating expenses | - 206 | - 183 | - 212 | - 189 | - 180 |
| Impairment | 11 | 92 | 47 | 3 | 35 |
| Impairment on Loans and receivables | 12 | 92 | 48 | 8 | 37 |
| Impairment on available-for-sale assets | - 1 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | - 1 | - 1 | 0 | - 5 | - 2 |
| Share in results of assoc. comp & joint-ventures | 2 | 1 | 1 | 0 | 0 |
| Result before tax | 94 | 207 | 137 | 119 | 125 |
| Income tax | - 15 | - 30 | - 22 | 20 | - 19 |
| Result after tax | 78 | 177 | 114 | 139 | 106 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 78 | 177 | 114 | 139 | 106 |
| Banking | 71 | 171 | 106 | 135 | 99 |
| Insurance | 7 | 6 | 9 | 5 | 7 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 19 923 | 19 991 | 17 667 | 17 163 | 17 642 |
| Required capital, insurance (Solv.II as of '16) | 97 | 94 | 93 | 95 | 91 |
| Allocated capital (end of period) | 2 169 | 2 173 | 1 931 | 1 854 | 1 899 |
| Return on allocated capital (ROAC) | 16% | 36% | 23% | 28% | 22% |
| Cost/income ratio, banking | 72% | 61% | 72% | 61% | 67% |
| Combined ratio, non-life insurance | 98% | 93% | 85% | 98% | 97% |
| Net interest margin, banking | 2,83% | 2,72% | 2,67% | 2,70% | 2,52% |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 63 | 60 | 58 | 59 | 58 |
| Non-life insurance before reinsurance | 9 | 9 | 9 | 9 | 8 |
| Earned premiums Non-life | 26 | 25 | 23 | 22 | 21 |
| Technical charges Non-life | - 17 | - 15 | - 14 | - 13 | - 13 |
| Life insurance before reinsurance | 2 | 2 | 2 | 3 | - 1 |
| Earned premiums Life | 4 | 4 | 4 | 4 | 4 |
| Technical charges Life | - 2 | - 2 | - 2 | - 1 | - 5 |
| Ceded reinsurance result | 0 | - 1 | 0 | - 1 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 14 | 14 | 19 | 15 | 18 |
| Net Realised result from Available for sale assets | 0 | 0 | 1 | 0 | 0 |
| Net Fee and Commission Income | 41 | 41 | 37 | 40 | 40 |
| Net other income | 1 | - 1 | 1 | 2 | 1 |
| Total income | 129 | 124 | 127 | 127 | 122 |
| Operating expenses | - 81 | - 77 | - 101 | - 82 | - 78 |
| Impairment | - 1 | 8 | 1 | 0 | 10 |
| Impairment on Loans and receivables | 0 | 9 | 1 | 1 | 11 |
| Impairment on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | 0 | 0 | 0 | - 1 | - 1 |
| Share in results of assoc. comp & joint-ventures | 0 | 0 | 0 | 0 | 0 |
| Result before tax | 47 | 55 | 26 | 45 | 55 |
| Income tax | - 8 | - 8 | - 6 | - 21 | - 13 |
| Result after tax | 40 | 47 | 20 | 23 | 42 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 40 | 47 | 20 | 23 | 42 |
| Banking | 37 | 46 | 17 | 21 | 40 |
| Insurance | 2 | 2 | 3 | 2 | 2 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 671 | 5 379 | 5 551 | 5 199 | 5 562 |
| Required capital, insurance (Solv.II as of '16) | 36 | 34 | 34 | 33 | 29 |
| Allocated capital (end of period) | 626 | 593 | 611 | 566 | 599 |
| Return on allocated capital (ROAC) | 25% | 30% | 12% | 15% | 28% |
| Cost/income ratio, banking | 63% | 62% | 81% | 65% | 63% |
| Combined ratio, non-life insurance | 99% | 92% | 84% | 99% | 101% |
| Net interest margin, banking |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 52 | 53 | 53 | 56 | 53 |
| Non-life insurance before reinsurance | 6 | 6 | 6 | 5 | 5 |
| Earned premiums Non-life | 9 | 9 | 8 | 9 | 8 |
| Technical charges Non-life | - 3 | - 3 | - 2 | - 3 | - 3 |
| Life insurance before reinsurance | 3 | 3 | 3 | 3 | 3 |
| Earned premiums Life | 10 | 13 | 13 | 12 | 13 |
| Technical charges Life | - 7 | - 10 | - 9 | - 9 | - 10 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 3 | 5 | 4 | 2 | 2 |
| Net Realised result from Available for sale assets | 0 | 0 | 0 | 1 | 0 |
| Net Fee and Commission Income | 12 | 13 | 12 | 11 | 12 |
| Net other income | 2 | 2 | 2 | 2 | 1 |
| Total income | 77 | 82 | 81 | 82 | 76 |
| Operating expenses | - 48 | - 49 | - 50 | - 55 | - 48 |
| Impairment | - 7 | - 1 | - 2 | - 7 | - 1 |
| Impairment on Loans and receivables | - 7 | - 1 | - 2 | - 7 | - 1 |
| Impairment on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | 0 | 0 | 0 | 0 | 0 |
| Result before tax | 22 | 32 | 28 | 20 | 26 |
| Income tax | - 5 | - 7 | - 6 | - 4 | - 6 |
| Result after tax | 16 | 25 | 22 | 16 | 20 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 16 | 25 | 22 | 16 | 20 |
| Banking | 14 | 22 | 19 | 14 | 17 |
| Insurance | 3 | 3 | 3 | 2 | 3 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 4 826 | 4 910 | 4 716 | 4 635 | 4 480 |
| Required capital, insurance (Solv.II as of '16) | 23 | 23 | 23 | 23 | 25 |
| Allocated capital (end of period) | 525 | 534 | 513 | 499 | 484 |
| Return on allocated capital (ROAC) | 13% | 19% | 17% | 13% | 17% |
| Cost/income ratio, banking | 64% | 60% | 64% | 66% | 65% |
| Combined ratio, non-life insurance | 85% | 82% | 73% | 94% | 87% |
| Net interest margin, banking |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 40 | 12 | 12 | 13 | 12 |
| Non-life insurance before reinsurance | - 7 | 8 | 10 | 10 | 10 |
| Earned premiums Non-life | 21 | 24 | 21 | 22 | 21 |
| Technical charges Non-life | - 28 | - 16 | - 12 | - 12 | - 11 |
| Life insurance before reinsurance | 1 | 1 | 1 | 1 | 1 |
| Earned premiums Life | 4 | 4 | 6 | 5 | 3 |
| Technical charges Life | - 2 | - 3 | - 5 | - 4 | - 2 |
| Ceded reinsurance result | 14 | 0 | - 1 | - 1 | - 1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 7 | 1 | 1 | 1 | 0 |
| Net Realised result from Available for sale assets | 1 | 0 | 1 | 0 | 0 |
| Net Fee and Commission Income | 11 | - 1 | - 1 | - 1 | - 1 |
| Net other income | - 4 | 1 | 0 | - 1 | 0 |
| Total income | 64 | 22 | 22 | 21 | 23 |
| Operating expenses | - 33 | - 13 | - 16 | - 15 | - 13 |
| Impairment | - 7 | - 3 | - 1 | - 2 | - 1 |
| Impairment on Loans and receivables | - 7 | - 3 | - 1 | 1 | - 1 |
| Impairment on available-for-sale assets Impairment on goodwill |
- 1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
| Impairment on Other | 0 | 0 | 0 | - 3 | 0 |
| Share in results of assoc. comp & joint-ventures | 1 | 0 | 0 | 0 | 0 |
| Result before tax | 25 | 6 | 5 | 4 | 9 |
| Income tax | - 3 | 0 | - 1 | 1 | - 1 |
| Result after tax | 22 | 5 | 4 | 5 | 8 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 22 | 5 | 4 | 5 | 8 |
| Banking | 21 | 4 | 3 | 4 | 5 |
| Insurance | 1 | 1 | 1 | 1 | 2 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 037 | 3 037 | 842 | 839 | 799 |
| Required capital, insurance (Solv.II as of '16) | 38 | 37 | 37 | 39 | 37 |
| Allocated capital (end of period) | 338 | 353 | 125 | 125 | 119 |
| Return on allocated capital (ROAC) | 49% | 16% | 13% | 16% | 22% |
| Cost/income ratio, banking | 49% | 56% | 72% | 66% | 53% |
| Combined ratio, non-life insurance | 102% | 98% | 96% | 98% | 97% |
| Net interest margin, banking |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Net Interest Income | 70 | 69 | 66 | 69 | 61 |
| Non-life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Non-life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Non-life | 0 | 0 | 0 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net Result from FIFV through profit or loss | 0 | 0 | 5 | 7 | - 9 |
| Net Realised result from Available for sale assets | 0 | 0 | 0 | 0 | 0 |
| Net Fee and Commission Income | 0 | 0 | 0 | - 1 | 0 |
| Net other income | - 55 | 0 | 0 | - 1 | - 4 |
| Total income | 16 | 69 | 71 | 75 | 49 |
| Operating expenses | - 43 | - 42 | - 44 | - 36 | - 40 |
| Impairment | 26 | 87 | 50 | 12 | 27 |
| Impairment on Loans and receivables | 26 | 87 | 50 | 12 | 28 |
| Impairment on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | 0 | 0 | 0 | 0 | - 1 |
| Share in results of assoc. comp & joint-ventures | 0 | 0 | 0 | 0 | 0 |
| Result before tax | - 1 | 113 | 76 | 51 | 35 |
| Income tax | 0 | - 14 | - 10 | 44 | 1 |
| Result after tax | - 1 | 99 | 67 | 95 | 37 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | - 1 | 99 | 67 | 95 | 37 |
| Banking | - 1 | 99 | 67 | 95 | 37 |
| Insurance | 0 | 0 | 0 | 0 | 0 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 525 | 6 652 | 6 544 | 6 477 | 6 787 |
| Required capital, insurance (Solv.II as of '16) | - | - | - | - | - |
| Allocated capital (end of period) | 679 | 692 | 681 | 664 | 696 |
| Return on allocated capital (ROAC) | -1% | 57% | 38% | 52% | 20% |
| Cost/income ratio, banking | 271% | 62% | 63% | 49% | 83% |
| Combined ratio, non-life insurance | - | - | - | - | - |
| Net interest margin, banking |
| in millions of EUR | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
|---|---|---|---|---|---|
| Operating expenses of group activities | -20 | -14 | -14 | -39 | -21 |
| Capital and treasury management-related costs | 5 | 17 | -18 | 4 | -4 |
| Costs related to the holding of participations | -13 | -13 | -9 | -14 | -13 |
| Results of remaining companies earmarked for divestment or in run-down | |||||
| 19 -3 |
11 10 |
83 -9 |
14 11 |
17 -14 |
|
| Other items | |||||
| Total net result for the Group Centre | -12 | 12 | 33 | -24 | -36 |
| Group Centre - Breakdown P&L | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 | 3Q 2016 |
| Net Interest Income | 7 | 2 | -5 | -7 | -13 |
| Non-life insurance before reinsurance | 3 | 3 | 1 | 8 | 5 |
| Earned premiums Non-life | 2 | 2 | 2 | 3 | 2 |
| Technical charges Non-life | 0 | 1 | -1 | 5 | 3 |
| Life insurance before reinsurance | 0 | 1 | -1 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 1 | -1 | 0 | 0 |
| Ceded reinsurance result | 1 | 0 | 1 | -2 | -12 |
| Dividend income | 1 | 6 | 2 | 3 | 2 |
| Net Result from FIFV through profit or loss | -2 | 37 | -44 | 2 | -31 |
| Net Realised result from Available for sale assets | 16 | 14 | 9 | 0 | 13 |
| Net Fee and Commission Income | -1 | -1 | -3 | -2 | -2 |
| Net other income | 5 | 2 | 1 | 30 | 2 |
| Total income | 30 | 63 | -38 | 32 | -35 |
| Operating expenses | -35 | -33 | -29 | -67 | -41 |
| Impairment | -6 | -11 | 4 | -5 | -20 |
| Impairment on Loans and receivables | -6 | -11 | 4 | -5 | -20 |
| Impairment on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | 0 | 0 | 0 | 1 | 1 |
| Result before tax | -11 | 18 | -63 | -39 | -95 |
| Income tax | -1 | -7 | 96 | 15 | 59 |
| Result after tax | -12 | 12 | 33 | -24 | -36 |
| Attributable to Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | -12 | 12 | 33 | -24 | -36 |
| Banking | 6 | 17 | 38 | -11 | -14 |
| Insurance | 2 | 1 | 2 | 11 | -4 |
| Group | -20 | -7 | -7 | -24 | -17 |
| Risk-weighted assets, banking (end of period, Basel III, fully loaded in '17, phased-in '16) | 3 636 | 4 058 | 4 407 | 4 186 | 4 921 |
| Risk-weighted assets, insurance (end of period, Basel II Danish compromise) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period, Solv.II as of '16) | 10 | 10 | 3 | - 18 | - 18 |
| Allocated capital (end of period) | 369 | 432 | 461 | 428 | 487 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) | 'Consolidated income statement' | 2 176 | 2 427 | 1 742 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) | 'Consolidated statement of changes in equity' | - 39 | - 52 | - 39 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) | Note 5.10 | 418,4 | 418,1 | 418,1 |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the | 418,4 | 418,1 | 418,1 | |
| period (D) | ||||
| Basic = (A-B) / (C) (in EUR) | 5,11 | 5,68 | 4,07 | |
| Diluted = (A-B) / (D) (in EUR) | 5,11 | 5,68 | 4,07 |
Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Net technical insurance charges, including the internal cost of settling claims (A) | Note 3.7.1 | 568 | 839 | 636 |
| / | ||||
| Net earned insurance premiums (B) | Note 3.7.1 | 1 089 | 1 387 | 1 031 |
| + | ||||
| Operating expenses (C) | Note 3.7.1 | 362 | 459 | 347 |
| / | ||||
| Net written insurance premiums (D) | Note 3.7.1 | 1 156 | 1 406 | 1 091 |
| = (A/B)+(C/D) | 83,4% | 93,2% | 93,5% |
A risk-weighted measure of the group's solvency, based on common equity tier-1 capital.
| Calculation (in millions of EUR or %) Reference |
9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|
| 'Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | |||
| Phased-in* | 16,1% | 16,2% | 15,1% |
| Fully loaded* | 15,9% | 15,8% | 15,3% |
* CRD IV capital rules are being implemented gradually to allow banks to build up the necessary capital buffers. The capital position of a bank taking into account the transition period is called 'phased-in'. The capital position of a bank based on a full application of all rules as applicable after the transition period is called 'fully loaded'.
Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Operating expenses of the banking activities (A) | 'Consolidated income statement': component of | 2 684 | 3 437 | 2 624 |
| 'Operating expenses' | ||||
| / | ||||
| Total income of the banking activities (B) | 'Consolidated income statement': component of 'Total | 4 952 | 6 238 | 4 587 |
| income' | ||||
| =(A) / (B) | 54,2% | 55,1% | 57,2% |
Where relevant, we also estimate exceptional and/or non-operating items when calculating the cost/income ratio. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 53,5% in 9M 2017 (versus 56,7% in 9M 2016).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Specific impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 777 | 4 874 | 5 030 |
| / Outstanding impaired loans (B) |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
10 060 | 10 583 | 11 023 |
| = (A) / (B) | 47,5% | 46,1% | 45,6% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period (in this case, a year), relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) (annualised) | 'Consolidated income statement': component of 'Impairment' |
- 54 | 126 | 72 |
| / Average outstanding loan portfolio (B) |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
151 271 | 146 257 | 145 359 |
| = (A) (annualised) / (B) | -0,05% | 0,09% | 0,07% |
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the new definition of 'nonperforming' used by the European Banking Authority.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit | 10 060 | 10 583 | 11 023 |
| risk' section | ||||
| / | ||||
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' | 153 339 | 147 526 | 145 692 |
| section | ||||
| = (A) / (B) | 6,6% | 7,2% | 7,6% | |
Where appropriate, the numerator may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12).
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Regulatory available tier-1 capital (A) | 'Leverage ratio KBC Group (Basel III fully loaded' | 15 996 | 15 286 | 14 993 |
| table in the 'Leverage KBC Group' section | ||||
| / | ||||
| Total exposure measures (total of non-risk-weighted on and off-balance sheet items, | Based on the Capital Requirements Regulation (CRR) | 277 675 | 251 891 | 243 615 |
| with a number of adjustments) (B) | ||||
| = (A) / (B) | 5,8% | 6,1% | 6,2% |
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) / |
Based on the European Commission's Delegated Act on LCR |
76 250 | 65 400 | 59 100 |
| Total net cash outflows over the next 30 calendar days (B) | 50 800 | 47 100 | 43 250 | |
| = (A) / (B) | 150,1% | 138,8% | 136,5% |
Gives an idea of the magnitude of (what are mainly pure, traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Loans and advances to customers (related to the group's banking activities) (A) | Note 4.1, component of 'Loans and advances to customers' | 138 098 | 131 415 | 130 290 |
| - | ||||
| Reverse repos with customers (B) | Note 4.1 | - 928 | - 376 | - 563 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (related to the group's banking activities) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
7 257 | 7 114 | 7 120 |
| + | ||||
| Loans and advances to credit institutions and investment firms (related to the group's banking activities, excluding dealing room activities) (D) + |
Note 4.1, component of 'Loans and advances to credit institutions and investment firms ' |
982 | 952 | 972 |
| Financial guarantees granted to clients (E) | Note 6.1, component of 'Financial guarantees given' | 7 972 | 8 279 | 7 417 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' | 4 819 | 5 094 | 5 237 |
| + | ||||
| Other (including accrued interest) (G) | Component of Note 4.1 | - 4 862 | - 4 952 | - 4 780 |
| = (A)-(B)+(C)+(D)+(E)+(F)+(G) | 153 339 | 147 526 | 145 692 |
Indicates the extent to which a bank has sufficient own funds and eligible liabilities available for bail-in. MREL and bail-in are based on the idea that shareholders and debt-holders should bear losses first if a bank fails.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Own funds* and eligible liabilities (issued from KBC Group NV) (A) | Based on BRRD | 21 677 | 18 467 | 17 424 |
| => based on the strategy of KBC to issue MREL eligible instruments from the Holding | ||||
| company | ||||
| / | ||||
| Risk weighted assets (consolidated, Danish compromise method) (B) | 'Consolidated balance sheet' | 91 535 | 87 782 | 88 967 |
| = (A) / (B) | 23,7% | 21,0% | 19,6% | |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) (annualised) | 'Consolidated income statement': component of 'Net interest | 2 629 | 3 602 | 2 702 |
| income' | ||||
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of 'Total assets' | 186 736 | 184 117 | 183 823 |
| = (A) (annualised x360/number of calendar days) / (B) | 1,86% | 1,92% | 1,94% | |
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel Committee on | 155 250 | 144 150 | 141 000 |
| Banking Supervision publication, October 2014) | ||||
| / | ||||
| Required amount of stable funding (B) | 119 550 | 114 950 | 114 850 | |
| = (A) / (B) | 129,9% | 125,4% | 122,8% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 17 003 | 15 957 | 15 135 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) | Note 5.10 | 418,3 | 418,4 | 418,1 |
| = (A) / (B) (in EUR) | 40,6 | 38,1 | 36,2 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) | Note 2.1: Segment reporting based on the management structure |
1 240 | 1 433 | 993 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset |
6 039 | 6 092 | 5 943 | |
| equivalents for the insurance activities (under Solvency I for '15 & II for '16) (B) = (A) annualised / (B) |
27,4% | 23,5% | 22,3% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) | Note 2.1: Segment reporting based on the management structure |
534 | 596 | 465 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency I for '15 & II for '16) (B) |
1 591 | 1 455 | 1 427 | |
| = (A) annualised / (B) | 44,4% | 40,9% | 43,4% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) | Note 2.1: Segment reporting based on the management structure |
370 | 428 | 289 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency I for '15 & II for '16) (B) |
2 011 | 1 959 | 1 946 | |
| = (A) annualised / (B) | 24,5% | 21,9% | 19,8% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) (annualised) | 'Consolidated income statement' | 2 176 | 2 427 | 1 742 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) (annualised) | 'Consolidated statement of changes in equity' | - 39 | - 52 | - 39 |
| / | ||||
| Average parent shareholders' equity, excluding the revaluation reserve for available-for | 'Consolidated statement of changes in equity' | 14.795 | 13.415 | 12.859 |
| sale assets (C) | ||||
| = (A-B) (annualised) / (C) | 19,3% | 17,7% | 17,7% |
Measures the solvency of the insurance business, calculated under Solvency II.
| Calculation | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Detailed calculation under 'Solvency II, KBC Insurance consolidated' table in the | 221% | 203% | 170% | |
| Solvency banking and insurance activities separately section |
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 202,2 | 198,9 | 194,5 |
| + | ||||
| Czech Republic Business Unit (B) | 9,3 | 8,5 | 9,0 | |
| + | ||||
| International Markets Business Unit (C) | 5,9 | 5,7 | 6,0 | |
| A)+(B)+(C) | 217,4 | 213,1 | 209,5 |
A risk-weighted measure of the group's solvency, based on total regulatory capital.
| Calculation | 9M 2017 | 2016 | 9M 2016 |
|---|---|---|---|
| Detailed calculation in the table 'Danish Compromise' under 'Solvency KBC Group' | |||
| section | |||
| Phased-in* | 20,1% | 20,6% | 19,5% |
| Fully loaded* | 19,9% | 20,0% | 19,4% |
* CRD IV capital rules are being implemented gradually to allow banks to build up the necessary capital buffers. The capital position of a bank taking into account the transition period is called 'phased-in'. The capital position of a bank based on a full application of all rules as applicable after the transition period is called 'fully loaded'.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.